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ABSTRACT 
In 1971 Schally and co-workers (Schally et aZ., 1971) isolated 
gonadotropin-releasing hormone (now called luteinizing hormone-releasing 
hormone (LH-RH)) from sheep hypothalami and established that the hormone 
was a decapeptide with the amino acid sequence: 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 • 
The peptide was subsequently synthesised (Matsuo et aZ., 1971b) and shown 
to stimulate the release of gonadotropins (luteinizing hormone and 
follicle-stimulating hormone) in a wide range of mammalian species 
(Schally et al., 1973, 1976). With the exception of amphibians, 
nonmammalian vertebrates have a poor gonadotropin response to synthetic 
mammalian LH-RH (for reviews, see Ball, 1981; Jackson, 1981; King and 
Millar, 1981a). Since there is considerable molecular heterogeneity 
in the related neurohypophysial nonapeptide hormones (oxytocin-vaso-
pressin) amongst vertebrates (Acher et al., 1972) , we postulated that 
differences might exist in the structure of hypothalamic LH-RH in 
different vertebrate classes, Utilising a combination of region-
specific antisera and chromatographic techniques, we established that 
amphibian hypothalamic LH-RH is identical to the mammalian peptide while 
avian, reptilian, and piscine hypothalamic LH-RHs differ structurally in 
the region Gly6-Leu7-Arg8 (King and Millar, 1979a, 1980), We have now 
conducted further studies on avian hypothalamic LH-RH , which indicate 
that the arginine residue in position eight of mammalian LH-RH is sub-
stituted by glutamine in this vertebrate class. Purification of LH-RH 
from chicken hypothalami and determination of the amino acid composition 
have confirmed that the structure of avian LH-RH is: 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-GZn-Pro-Gly-NH2 . 
For indirect structural analysis, chicken LH-RH was partially . 
purified by immunoaffinity chromatography utilising a mammalian LH-RH 
(iii) 
antiserum coupled to Sepharose. Binding of this partially purified 
chicken LH-RH with five different region-specific antisera raised 
against mammalian LH-RH was compared by radioimmunoassay. With anti-
sera which require the NH2- and COOH-termini for effective binding, 
quantitation was highest (denoted 100%) and parallel displacement curves 
were obtained. All other antisera yielded nonparallel displacement 
curves. With antisera which require the middle region of LH-RH (Trp3 to 
Pro9) for binding, relative quantitation was 17-30%; with a COOH-ter-
minus-directed antiserum (requiring Arg8 to Gly10-NH2) relative 
quantitation was only 6%. These data indicate a difference in the 
structure of chicken LH-RH at position eight (arginine). Studies com-
paring antiserum interaction with chicken LH-RH after chemical modific-
ation of specific amino acid residues and after cleavage with specific 
proteolytic enzymes supported this conclusion . On gel filtration 
chromatography (Sephadex G-25 and Bio-Gel P-2) chicken LH-RH eluted in 
an identical position to mammalian LH-RH. In cation exchange chromato-
graphic systems (CM32 carboxymethyl cellulose chromatography and Partisil 
PXS 10/25 SCX high performance liquid chromatography) chicken LH-RH con-
sistently eluted. earlier than the mammalian peptide. These studies 
demonstrate that chicken LH-RH is of similar size but is less positively 
charged than mammalian LH-RH. The pI for chicken LH-RH was found to be 
7.3 by isoelectric focusing. This is compatible with a neutral amino 
acid substitution for arginine at position eight . On the basis of con-
formational criteria and evolutionary probability of amino acid inter-
change for arginine, the most likely substitution is glutamine. We 
therefore synthesised [Gln8]LH-RH by the solid-phase method and 
established that the synthetic peptide elutes identically in a wide 
range of chromatographic systems, has an isoelectric point identical 
(iv) 
to that of natural chicken LH-RH, and has similar immunological 
properties. Synthetic [Gln8]LH-RH ~lso displayed similar activity to 
natural chicken LH-RH in stimulating the release of luteinizing 
hormone from dispersed chicken anterior pituitary cells, Both the 
natural and synthetic chicken peptides had similar low potency in 
stimulating luteinizing hormone release from mammalian (sheep) 
anterior pituitary cells in culture (approximately 10% of the potency 
of mammalian LH-RH). 
In order to isolate pure chicken LH-RH, it was estimated 
that approximately 250,000 hypothalami would be required to obtain 50 µg 
of pure peptide. This number of hypothalami was collP.cted, and 
extracted with 2 N acetic acid which yielded 33.7 µg immunoreactive 
LH-RH in 22.2 g of dry material, The extract was purified by immuno-
affinity chromatography (yield was 24 . 4 µg immunoreactive LH-RH in 
0.100 g dry weight) followed by cation exchange and reverse phase high 
performance liquid chromatography to give a final yield of 17.4 µg 
homogeneously pure LH-RH . This represents a purification of two 
million-fold and a recovery from starting material of 51%. Amino acid 
analysis of a 6 N HCl hydrolysate gave ratios Ser 1, Glu 2, Pro 1, Gly 2, 
Leu 1, Tyr 1, Trp 1 and His 1, confirming the indirect demonstration that 
arginine in position eight of mammalian LH-RH is substituted by 
glutamine. 
A number of studies on the gonadotropin-releasing activity of 
chicken LH-RH in different vertebrates have been initiated . Results show 
that chicken LH-RH is equipotent with mammalian LH-RH in stimulating 
luteinizing hormone release from dispersed chicken anterior pituitary 
cells. Mammalian LH-RH has poor gonadotropin-releasing activity in 
(v) 
fish (Ball, 1981; Jackson, 1981; King and Millar, 1981a), and it is 
possible that the synthetic avian peptide will be more active in fish. 
Induction of spawning in fish is an important economic component of 
productivity in pisciculture. Attempts to substitute mammalian LH-RH 
(and analogues) for the expensive mammalian gonadotropins that have 
been used to induce spawning, have been relatively unsuccessful. 
Howeve~, synthetic avian LH-RH and, in particular, superactive analogues 
of the peptide, might be effective in stimulating reproduction in fish 
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1.0 PHYLOGENY OF LUTEINIZING HORMONE-RELEASING HORMONE 
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It is now generally accepted that in all vertebrates (with 
the possible exception of cyclostomes) the gonadotropic function of the 
anterior pituitary is regulated by the hypothalamus via the secretion 
of releasing and/or release-inhibiting factors into a hypothalamo-
pituitary portal vascular system (for reviews, see Crim et al., 1978; 
Goos, 1978; Jackson, 1978; Ball, 1981), However, the possibility that 
gonadotropin release is also, or independently, regulated via direct 
neural control or hormonal regulation via the general circulation has 
not been excluded, 
The first definitive evidence for the existence of an anterior 
pituitary gonadotropin-releasing factor or hormone was .provided by 
Mccann et al. (1960), who showed that acid extracts of the mammalian 
median eminence could induce release of luteinizing hormone (LH) from 
the mammalian anterior pituitary. Subsequently, the LH-releasing 
hormone (LH-RH) was isolated from porcine (Schally et al., 1971) and 
ovine (Burgus et al., 1972) hypothalamic extracts and characterised as 
a decapeptide pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (Matsuo 
et al., 1971a). The synthesised peptide (Matsuo et al., 1971b) 
releases LH as well as follicle-stimulating hormone (FSH) in a wide 
variety of mammalian species ' (for reviews, see Schally et al., 1973, 
1976), suggesting that it is also the FSH-RH, so that this decapeptide 
is p'erhaps more correctly called gonadotropin-releasing hormone. For 
convenience, I shall refer to the gonadotropin-releasing hormone as 
LH-RH. 
PHYLOGENETIC DISTRIBUTION AND FUNCTION OF LH-RH 
Mammals 
Mammalian LH-RH has been studied extensively and well re-
viewed, and will therefore be omitted from this review. 
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Birds 
The secretion and release of gonadotropins from the anterior 
pituitary in birds is regulated by the hypothalamus (Dodd et al., 1971). 
Evidence for this concept was first provided by experiments in which 
intrapituitary infusion of domestic fowl hypothalamic extracts evoked 
premature ovulation in domestic fowl (Clark and Fraps , 1967; Opel and 
Lepore, 1967, 1972). Subsequently, hypothalamic extracts from domestic 
fowl and quail have been shown to stimulate the release of LH from 
domestic fowl and quail pituitaries in vitro (Jackson and Nalbandov, 
1969; Tanaka et al., 1969; Follett, 1970; Casey et al., 1971; Smith 
and Follett, 1972; Campbell and Wolfson, 1974; Harrison et al., 1974; 
Bicknell and Follett, 1977; Hattori et al., 1980; Kawashima et al., 
1981). LB-releasing activity has been demonstrated in hypothalamic 
extracts of domestic fowl (Jackson and Nalbandov , 1969; Jackson, 1971a, 
1971b, 1972) and quail (H~ttori et al., 1980) tested on the rat anterior 
pituitary in vitro, and in extracts of domestic fowl tested on the sheep 
anterior pituitary in vitro (King and Millar, 1980, 1981a) . The results 
of lesioning and deafferentation experiments in the turkey (Opel, 1979) 
and electrical stimulation and lesion studies in the quail (Davies and 
Follett, 1980) are consistent with the view that a gonadotropin-releas-
ing factor is located in the hypothalamus. 
Synthetic mammalian LH-RH (microgram rather than nanogram doses 
are necessary to evoke a response) elicits precocious ovulation in the 
domestic fowl (van Tienhoven and Schally , 1972; Tanaka et al., 1974; 
Tanaka and Kamiyoshi, 1976; Johnson and van Tienhoven , 1981); induces 
ovarian growth in the domestic fowl (Reeves et al., 1973) and turkey 
(Burke and Cogger, 1977); increases serum LH levels in the domestic fowl 
(Furr et al., 1973; Bonney et al., 197~; Wilson and Sharp, 1975; Williams 
and Sharp, 1978; Johnson and van Tienhoven, 1981; Tanabe et al., 1981), 
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turkey (Burke and Cogger , 1977), sparrow (Wingfield et al., 1979),. 
bantam (Sharp and Lea, 1981), quaii (Davies and Bicknell, 1976; Davies 
and Collins, 1979) and domestic duck (Balthazart et al., 1980); 
increases (only very slightly) serum levels of FSH in the domestic fowl 
(Godden et al., 1977; Scanes et al., 1977), domestic duck (Balthazart 
et al., 1980) and quail (Davies and Collins, 1979). In vitro studies 
have shown that synthetic mammalian LH-RH stimulates the secretion of 
LH (Bicknell and Follett, 1975; Gledhill, 1977) and FSH (Gledhill, 
1977) from the quail anterior pituitary. In the laying domestic fowl, 
the biological effects of endogenous gonadotropin-releasing hormone can 
be blocked by injection of antiserum to synthetic mammalian LH-RH 
(Fraser and Sharp, 1978). 
Further evidence for hypothalamic control of gonadotropic 
function in birds is provided by the following: in the domestic duck, 
pituitary responsiveness to synthetic mammalian LH-RH changes during the 
annual cycle (Balthazart et al., 1980); in the turkey, sex hormones 
alter the sensitivity of the anterior pituitary to synthetic mammalian 
LH-RH (Godden et al., 1977); anti-estrogen increases the responsiveness 
of the anterior pituitary of the domestic hen to an injection of synthetic 
mammalian LH-RH (Wilson and Cunningham, 1981); the sensitivity of the 
anterior pituitary to synthetic mammalian LH-RH is increased in quails 
at the beginning of gonadal maturation (Davies and Bicknell, 1976); 
synthetic mammalian LH-RH has a role in the reproductive behaviour of 
female ring doves (Cheng, 1977). Several analogues of synthetic 
mammalian LH-RH ([Phe 5]LH-RH, [des-Gly10]LH-RH) have been shown to be 
more potent than the decapeptide in stimulating LH release from domestic 
fowl anterior pituitaries in vitro (Bonney and Cunningham, 1977), but 
they were less potent on rat anterior pituitaries (Rivier et al., 1972; 
Coy et al., 1973). A superactive analogue of LH-RH ([D-Lys 6]LH-RH ethyl-
amide) has been shown to elevate plasma testosterone levels in domestic 
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cocks (Pethes et aZ., 1980). 
In radioimmunoassays, antisera raised against synthetic 
mammalian LH-RH cross-react with hypothalamic and extrahypothalamic 
brain extracts of the domestic fowl (Jeffcoate et aZ., 1974; King and 
Millar, 1979a, 1980, 1981a; Hattori et aZ., 1980) and pigeon (King and 
Millar, 1979a, 1980, 1981a). · Immunohistochemical staining for LH-RH 
has been reported in the median eminence of the domestic hen (Sterling 
and Sharp, 1982), cockerel (de Riviers and Dubois, 1974), greenfinch 
(Sharp et aZ., 1975), duck (Calas et aZ., 1973; McNeill et aZ., 1976; 
Eons et aZ., 1978), quail (Nozaki and Kobayashi, 1979; Hattori et aZ., 
1980) and pigeon (Weindl et aZ., 1982). 
Reptiles 
In reptiles, regulation of gonadotropic function is less well 
understood, Early indications of hypothalamic regulation of gonado-
tropins in reptiles came from findings that implants of testosterone 
or estradiol in or near the median eminence of the lizard inhibited 
testicular and ovarian growth (Lisk, 1967), suggesting that . the hypo-
thalamus stimulates gonadotropin secretion and is sensitive to the 
suppressive action of sex steroids. The results of Hall et aZ. (1978) 
regarding the effect of terrapin hypothalamic extracts on the release of 
LH from terrapin pituitaries in vitro were inconclusive, although 
tortoise hypothalamic extracts have been demonstrated to stimulate 
release of LH-like gonadotropin from frog pituitaries in vitro 
(Thornton and Geschwind, 1974). 
Synthetic mammalian LH-RH elevates plasma gonadotropin levels 
in the turtle (Callard and Lance, 1977), and Licht (1980) has recently 
shown that the synthetic mammalian hormone stimulates LH release, but 
y 
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not the release of FSH, in the turtle in vivo. Injection of synthetic 
mammalian LH-RH (microgram doses), and of synthetic mammalian thyro-
tropin-releasing hormone, induces sexual ~eceptivity in estrogen-primed, 
-
ovariectomised female lizards (Alderete et al., 1980). 
By radioimmunoassay, LH-RH-like immunoreactivity has been 
demonstrated in the hypothalamus and extrahypothalamic brain of the 
lizard and tortoise (King and Millar, 1979a, 1980, 1981a). Immuno-
histochemical studies have shown that immunoreactive LH-RH occurs in the 
median eminence and in other .brain areas of the lizard, gecko, turtle 
and snake (Doerr-Schott and Dubois, 1978 ; Nozaki and Kobayashi, 1979). 
Amphibians 
Amphibians possess a well-developed hypothalamo-pituitary 
portal vascular system , and evidence from hypothalamic lesions, pituitary 
stalk section and pituitary transplantation suggests that the secretion 
of anterior pituitary gonadotropins is regulated by the hypothalamus 
(Jorgensen and Larson, 1967). Homogenates of ·frog hypothalami stimulate 
the release of bioassayable LH-like gonadotropin from frog hemipituitaries 
in vitro (Thornton and Geschwind, 1974), and immunoreactive LH-RH from the 
clawed toad hypothalamus is equipotent with mammalian LH-RH in stimulating 
LH release from the sheep anterior pituitary in vitro (King and Millar, 
1980, 1981a). 
Synthetic mammalian LH-RH (microgram doses) was shown to 
stimulate secretion of LH-like gonadotropin from frog hemipituitaries 
in vitro (Thornton and Geschwind, 1974). In vivo studies have shown 
that synthetic mammalian LH-RH induces ovarian growth , ovulation and 
vitellogenesis in the clawed toad (Thornton and Geschwind, 1974), and 
spermiation in the frog (Licht, 1974; Easley et al., 1979). Synthetic 
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ma~alian LH- RH thus seemingly stimulates the release of both LH (f~r 
ovulation) and FSH (for ovarian growth and vitellogenesis) in these 
anurans. This would accord with the action of synthetic mammalian LH-RH 
in mammals where release of both LH and FSH is brought about in vivo 
and in vitro (Blackwell and Guillemin, 1973; Schally, 1978). Recently, 
Daniels and Licht (1980) have confirmed that synthetic mammalian LH-RH 
stimulates release of both LH and FSH in the frog in vivo. Two analog-
ues of synthetic mammalian LH-RH (an agonist and an antagonist) were 
shown to possess actions in the frog similar to those exhibited in mammals 
(Mccreery et al., 1982). The agonist ([imBzl-D-His6 , Pro9-Net]LH-RH) was 
more potent and had a longer duration of action in stimulating in vivo 
LH and FSH secretion in frogs. Pretreatment with antagonist 
([(Ac-dehydro-Pro 1 , pCl-D-Phe2 , D-Trp3• 6 )-Na-MeLeu7]LH-RH) suppressed 
LH-RH-induced gonadotropin release in adult male frogs. In the clawed 
toad, hypothalamic LH-RH content varies seasonally in parallel with 
seasonal changes in ovarian weight (King and Millar, 1979b), suggesting 
a possible role for hypothalamic LH-RH in gonadotropic function. 
Amongst urodele amphibians, perifusion of the newt pituitary 
in vitro by synthetic mammalian LH-RH induces ovulation (Vellano et al., 
1974), and synthetic mammalian LH-RH perifused into newts bearing ectopic 
pituitary autografts restores spermatogenesis (Mazzi et al., 1974) and 
promotes oocyte recruitment (Mazzi, 1978). 
Radioimmunoassay studies employing antisera raised against 
synthetic mammalian LH-RH have demonstrated the presence of immuno-
reactive LH-RH in the hypothalamus and extrahypothalamic brain of the 
frog, toad and clawed toad (Deery, 1974; Alpert ~t al., 1976; King 
and Millar, 1979a, 1979b, 1980, 1981a, 1981b; Rivier et al., 1981), 
and in the sympathetic ganglia of the frog (Jan et al., 1979; Eiden 
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and Eskay, 1980). Immunohistochemical studies have demonstrated neµrons 
reacting with anti-LH-RH in the median eminence and other brain areas of 
the frog, toad, clawed toad and newt (Doerr-Schott and Dubois, 1975, 1976, 
1978; Alpert et al., 1976; Dubois, 1976; Goos et al., 1976; Goos and 
van Oordt, 1978; Doerr-Schott et al., 1978, 1979; Kubo et al., 1979; 
Nozaki and Kobayashi, 1979), and in the sympathetic ganglia of the frog 
(Jan et al., 1980). 
Fish 
Evidence for hypothalamic control of the gonadal activity and 
gonadotropin secretion in fish has been reported (Peter, 1970, 1973; 
Peter and Crim, 1979). Gonadotropin-releasing activity has been demon-
. strated in hypothalamic extracts from various teleost fish (carp, trout, 
cichlid, goldfish) tested on the teleost pituitary in vivo and in vitro 
(Breton et al., 1971a, 1971b, 1972, 1975a, 1975b; Breton and Weil, 1973; 
Holmes and Ball, 1974; Weil et al., 1975; de -Vlaming and Vodicnik, 1975, 
1977; Crim et al., 1976; Barnett et al., 1979; Crim and Evans, 1980), 
on the rat pituitary in vivo . (Barnett et al., 1979), and on the sheep 
pituitary in vitro (Breton et al., 1972; King and Millar, 1980, 1981a). 
Hypothalamic extracts from sheep stimulate gonadotropin release from 
carp pituitaries in vitro (Breton et al., 1972), and rat hypothalamic 
extracts stimulate the release of gonadotropin from trout pituitaries 
in vitro (Crim and Evans, 1980). ' 
Synthetic mammalian LH-RH (microgram rather than nanogram 
doses are required to evoke a response) induces ovulation in the gold-
fish (Lam et al., 1975, 1976), ayu (Hirose and Ishida, 1974), medaka 
(Chan, 1977), plaice and goby (Aida et al., 1978), and various Chinese 
farm fish (carp) (Symposium Group for Hormonal Application in Pisci-
culture, 1975; Academia Sinica Cooperative Team, 1977), and stimulates 
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ovarian maturation in carp (Sokolowska et aZ., 1978; Weil et aZ., 1~80 ). 
Other studies have shown that synthetic mammalian LH-RH stimulates the 
in vivo release of gonadotropin in carp (Breton and Weil, 1973; Weil 
et aZ., 1975, 1980), trout (Crim and Cluett, 1974; Weil et al., 1978; 
Crim et al., 1981) and goldfish (Lam et al., 1975; Crim et al., 1976; 
Peter, 1980), and the in vitro release of gonadotropin from the trout 
pituitary (Crim and Evans, 1980; Crim et al., 1981). Synthetic mammal-
ian LH-RH also induces cytological activation of the gonadotropic cells 
of Poecilia latipinna, both in vitro and in vivo (Young and Ball, 1980), 
and of salmon (Ekengren et al., 1978), goldfish (Lam et aZ., 1976), 
medaka (Chan, 1977) and the grass carp (Academia Sinica Cooperative 
Team, 1978a, 1978b) in vivo. Several superactive analogues of synthetic 
mammalian LH-RH ([D-Ala6 , des-Gly1 0]LH-RH ethylamide and other analogues 
with D-amino acid substitutions in position six and/or an ethylamide) 
have equal or_greater biological activity than the synthetic decapeptide 
or the natural releasing hormone in various teleost fish (trout, gold-
fish, carp) in vivo and in vitro (Academia Sinica Cooperative Team, 1977; 
Cooperative Team for Hormonal Application in Pisciculture, 1977; 
Fukien-Kiansu Cooperative Group, 1977; Peter, 1980; Crim et aZ-., 1981). 
Although the synthetic mammalian decapeptide activates gonadal 
function in teleos t fish, it may not be identical to teleost hypothalamic 
LH-RH, since injection of hypothalamic extracts from the carp produces 
different profiles of carp gonadotropin secretion than does the synthetic 
mammalian LH-RH (Breton and Weil, 1973). Furthermore, higher doses of 
synthetic mammalian LH-RH are required to stimulate gonadotropin secretion 
in teleost fish than in mammals. 
Amongst elasmobranch fish, dogfish median eminence extracts and 
synthetic mammalian LH-RH have been shown to activate the adenyl cyclase 
- 9 -
system of the gonadotropin-containing ventral lobe of the dogfish . 
pituitary (Deery and Jones, 1975), ·and dogfish treated with synthetic 
mammalian LH-RH responded with elevated plasma gonadotropin levels in 
an ·experiment in which a heterologous radioimmunoassay was used to 
measure gonadotropin (Dodd, 1975). More recently, both dogfish hypo-
thalamic extracts and synthetic mammalian LH-RH were shown to raise 
circulating levels of sex steroids in male and female dogfish (Jenkins 
and Dodd, 1980). 
Th~ existence of hypothalamic control of the anterior pituit-
ary in cyclostome fish remains to be clearly established. An anatomical 
mechanism for the transfer of hypothalamic influences to the cyclostome 
anterior pituitary is lacking, or is very inefficient, as neither a 
portal system nor direct innervation of the anterior pituitary is present 
(for review, see Ball, 1981). There is no biological evidence indicating 
that gonadotropin release is stimulated by a hypothalamic gonadotropin-
releasing hormone in cyclostomes. 
Regarding the occurrence of immunoreactive LH-RH in the fish 
hypothalamus, Deery (1974) was unable to detect immunoreactive LH-RH 
in hypothalamic extracts of a teleost (goldfish) and elasmobranch (dog-
fish), and Crim et al. (1979a, 1979b) found no radioimmunoassayable 
LH-RH in the cyclostome (hagfish) braih. More recently, radioimmuno-
assay studies employing antisera raised against synthetic mammalian 
LH-RH have demonstrated the presence of immunoreactive LH-RH in the 
hypothalamus and in extrahypothalamic brain regions of teleosts (cichlid, 
codfish, carp, goldfish, catfish) (Peptide Hormone Group , 1977; Barnett 
et al., 1979, 1982; Jackson, 1979; King and Millar, 1979a, 1980, 1981a), 
elasmobranchs (dogfish, ratfish)(Crim et al., 1978; Jackson, 1978, 1979; 
King and Millar, 1979a, 1980, 1981a), and cyclostomes (hagfish, lamprey) 
I 
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(Jackson, 1979; King and Millar , 1980 , 1981a). By means of immunohisto-
chemistry, immunoreactive LH-RH has -been localised in the hypothalamus 
and extrahypothalamic brain of teleosts (trout, puffer, carp, platyfish) 
-
(Goos and Murathanoglu~ 1977; Goos and van Oordt, 1978; Dubois et aZ., 
1979; Nozaki and Kobayashi ., 1979; Schreibman et aZ., 1979), and cyclo-
stomes (lamprey, but not hagfish) (Crim et aZ., 1979a, 1979b). 
Other organisms 
In addition to the widespread distribution of an LH-RH-like 
substance amongst vertebrates, immunoreactive LH-RH has •also been des-
cribed in more primitive organisms. In the tunicate Ciona, neurosecret-
ory cells containing immunoreactive LH-RH occur in the cerebral ganglion 
of the adult but not in very young individuals (Georges and Dubois, 1980). 
A substance with LH-releasing activity has also been extracted from leaves 
of the plant Avena sativa (Fukushima et aZ., 1976). These observations 
are of great interest, but any explanation for the occurrence of LH-RH 
in these organisms would be speculative at this stage especially since 
LH-RH sequences have been noticed in a number of functionally unrelated 
molecules (Stewart and Channabasavaiah, 1979). 
STRUCTURE OF LH-RH 
The foregoing evidence for the presence of a biologically 
active gonadotropin-releasing hormone in the hypothalamus of all verte-
brate classes· is thus substantial. However, the structural and bio-
logical nature of LH-RH in submammalian vertebrates has not been well 
investigated. There is, therefore, the need to undertake a thorough 
investigation of the structure, and to isolate and characterise hypo-
thalamic LH-RH from submammalian vertebrates. 
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The structural nature of hypothalamic and extrahypothalamic 
brain LH-RH in submammalian vertebrates has been studied by radioimmuno-
assay and chromatography (for reviews, see Ball, 1981; Jackson, 1981; 
' 
-
King and Millar, 1981a). Several reports indicated a structural identity 
between mammalian hypothalamic LH-RH and chicken and frog hypothalamic 
LH-RHs(Deery, 1974; Jeffcoate et al., 1974; Alpert et al., 1976), 
whilst others reported differences in the physico-chemical and biologic-
al properties of chicken and teleost fish hypothalamic LH-RHs (Jackson, 
1971a, 1971b, 1972; Hattori et al., 1980; Jackson, 1981; Barnett et al., 
1982) and frog sympathetic ganglion LH-RH (Jan et al., 1979; Eiden and 
Eskay, 1980). On the basis of chromatographic properties and using 
region-specific antisera we demonstrated that avian, reptilian, and 
piscine hypothalamic LH-RHs differed structurally from mammalian hypo-
thalamic LH-RH, the difference being in the region Gly6-Leu7-Arg8 (King 
and Millar, 1979a, 1980, 1981a). Jackson's group (Jackson, 1981; 
Barnett et al., 1982) has recently identified two LH-RH molecules in 
teleost brain which appear to differ from one another and from synthetic 
mammalian LH-RH by a single amino acid substitution in position seven or 
eight, as well as a third immunoreactive material which appears to be a 
'big' LH-RH: We have shown that amphibian hypothalamic LH-RH is identic-
al to the mammalian hypothalamic decapeptide (King and Millar, 1979a, 
1979b~ 1980, 1981a, 1981b) and this has been confirmed by recent studies 
on the amino acid composition of frog brain LH-RH (Rivier et al., 1981). 
Frog sympathetic ganglion LH-RH, however, differs from mammalian hypo-
thalamic LH-RH in the COOH-terminal region of the molecule (Eiden and 
Eskay, 1980). 
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EVOLUTION OF LH-RH 
A comment on the evolution of vertebrate hypothalamic LH-RH 
is appropriate at this stage. Although bird, reptile, and teleost fish 
hypothalamic LH-RHs are structurally different from mammalian decapeptide 
LH-RH, they behave identically to each other on CM32 carboxymethyl 
cellulose cation exchange chromatography and reverse phase high perform-
ance liquid chromatography as well as in their interaction with region-
specific antisera (King and Millar, 1979a, 1980, 1981a). It is possible 
that the LH-RH in present-day birds, reptiles and teleosts represents 
the ancestral LH-RH molecule which occurred in the ancient osteichthyes 
and has persisted for about 400 million years. A single mutation in the 
ancestral 'avian-type' molecule might have occurred in a lineage common 
to amphibians and mammals in accordance with a coptemporary phylogenetic 
scheme (Licht et al., 1977), to give rise to the 'mammalian-type' 
analogue in present-day amphibians and mammals (King and Millar, 1979a, 
1981a). 
Synthetic mammalian LH-RH (and superactive analogues of the 
hormone) exhibit good gonadotropin-releasing activity in amphibians but 
have poor or no such activity in birds, reptiles and fish (for reviews, 
see Ball, 1981; Jackson, 1981; King and Millar, 1981a). It is likely 
that this phenomenon reflects structural differences in pituitary gonado-
trope receptors related to the structural difference of LH-RH in these 
vertebrate classes. 
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The objective of the present study was to determine the 
structural and biological nature of avian hypothalamic LH-RH. The 
thesis comprises three fields of study: 
a) 'Indirect' studies on partially purified chicken hypothalamic 
LH-RH utilising radioimmunoassay with region-specific antisera, 
several chromatographic systems, and comparison of antiserum 
interaction with chicken LH-RH after cleavage with proteolytic 
enzymes and chemical modification of specific amino acids . 
b) Isolation of pure chicken hypothalamic LH-RH, and determination 
of the amino acid composition and sequence of the peptide , 
c) Synthesis of chicken hypothalamic LH-RH, and assessment of the 
biological activity of the natural and synthetic peptides in 
the mammal and in the bird, using anterior pituitary cell culture 
and receptor binding techniques. 
' 
2.0 STRUCTURAL DETERMINATION OF PARTIALLY PURIFIED CHICKEN 
HYPOTHALAMIC LUTEINIZING HORMONE-RELEASING HORMONE 
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2.1 SUMMARY 
Studies on partially purified chicken hypothalamic luteiniz-
ing hormone-releasing hormone (LH-RH) utilising chromatography, region-
specific antisera, enzymic inactivation and chemical modification have 
established that the peptide is structurally different from mammalian 
hypothalamic LH-RH. Gel filtration chromatography demonstrated that 
chicken LH-RH is of the same molecular size as the mammalian decapeptide. 
Chicken LH-RH eluted earlier than mammalian LH-RH on reverse phase high 
performance liquid chromatography (HPLC). Cation exchange chromatography 
(CM32 carboxymethyl cellulose and HPLC) and isoelectric focusing establish-
ed that chicken LH-RH is less positively charged than the mammalian pep-
tide. Binding studies of chicken LH-RH utilising five different region-
specific antisera raised against mammalian LH-RH demonstrated that the 
structural difference resides in amino acid residue eight (arginine). 
This finding was confirmed by measurement, with appropriate antisera, of 
changes in immunoreactivity after cleavage with proteolytic enzymes and 
chemical modification of specific amino acid residues, The lower iso-
electric point of chicken LH-RH (7.3) relative to that of the mammalian 
peptide (9.1) is compatible with the substitution of a neutral amino acid 
for arginine at position eight. Structural studies on mammalian LH-RH 
have shown that the side chain of Arg8 is in close vicinity to the side 
chains of His2 and Tyr5 , and that these side chains are linked by hydrogen 
bonds and form a combined unit important for biological action (Shinitzky 
and Fridkin, 1976). A likely neutral amino acid substitution compatible 
with these structural requirements is glutamine. Moreover, of the 
neutral amino acids, the probability of glutamine replacing arginine 
(or vice versa) is high (Dayhoff et al., 1972), We therefore synthesised 
[Gln8]LH-RH and found it to have identical chromatographic, immunological 
and biological properties to the natural chicken peptide. 
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2.2 INTRODUCTORY STATEMENT 
The decapeptide LH-RH {pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-
Gly-NHz), originally isolated from porcine hypothalami (Matsuo et al., 
1971a) and later synthesised (Matsuo et al., 1971b), is biologically 
active in a large number of mammalian species. Synthetic mammalian LH-RH 
appears to have lower activity in birds, reptiles, amphibians and fish. 
Crude hypothalamic extracts from these submammalian vertebrates, never-
theless, contain significant gonadotropin-releasing activity and LH-RH-
like immunoreactivity has been demonstrated in the hypothalamus of these 
vertebrates by radioimmunoassay and immunocytochemistry (for reviews, 
see Ball, 1981; Jackson, 1981; King and Millar, 1981a), We have demon-
strated that immunoreactive amphibian hypothalamic LH-RH is identical 
to the mammalian decapeptide, while immunoreactive LH-RHs from avian, 
reptilian, and piscine hypothalami are structurally different (King 
and Millar, 1979a, 1980, 1981a). These differences of LH-RH-like 
peptides in submammalian vertebrates have not been determined, 
In view of the extremely small quantities of immunoreactive 
LH-RH present in hypothalamic tissue, several hundred thousand hypo-
thalami and a purification of a similar magnitude (Matsuo et al., 1971a) 
are required for structural determination. Since avian hypothalamic 
LH-RH appears to have considerable structural homology with mammalian 
decapeptide LH-RH (King and Millar, 
0
1979a, 1980), we considered it 
feasible to determine the structural differences on a small quantity of 
partially purified material by indirect means utilising a combination 
of chromatographic analysis, binding of region-specific antisera, 
enzymic inactivation, and chemical modification of specific amino 
acid residues. This section describes the structural characterisation 
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of chicken hypothalamic LH-RH, and establishes that the peptide differs 
from mammalian hypothalamic LH-RH at residue eight , arginine being 
substituted by glutamine. Based on these findings we synthesised 
[Gln8]LH-RH (see section 4,3) for comparison with natural chicken 
LH-RH, and report here that chicken hypothalamic LH-RH has identical 
properties to [GlnB]LH-RH. 
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2.3 MATERIALS AND METHODS 
Extraction and partial purification of chicken hypothalamic LH-RH 
Fragments of 15,000 chicken (Gallus domesticus) hypothalami 
consisting of the median eminence and pituitary stalk were dissected, 
lyophilised, defatted with petroleum ether (40-60°C), and extracted 
with 2 N acetic acid at 4°C. The supernatant extract was lyophilised, 
reconstituted in 0.5 M ammonium ·acetate, pH 7.0, and applied to an 
immunoaffinity column (2 x 22 cm) prepared by coupling rabbit gamma 
globulin (anti-LH-RH 1076) to cyanogen bromide-activated Sepharose 
4B (Pharmacia Fine Chemicals). The column was washed with 0.5 M 
ammonium acetate to remove unbound peptides, and immunoreactive LH-RH 
was- eluted with 1.5 N acetic acid. Aliquots of fractions were assayed 
for LH-RH immunoreactivity, and for total peptide using bovine serum 
albumin as standard (Lowry et al., 1951). The active fractions were 
pooled and lyophilised, and used in all studies described below. 
Chromatographic procedures 
In each chromatographic system the elution volume of synthetic 
mammalian LH-RH (Ayerst Laboratories) was determined for comparison with 
that of chicken LH-RH. Aliquots of column fractions were lyophilised 
and assayed for LH-RH immunoreactivity. 
Gel filtration chromatography - Immunoreactive chicken LH-RH 
was incubated at 50°C for 3 h in 2 ml 2 N acetic acid containing 6 M 
urea, and eluted on Sephadex G-25 superfine (1,6 x 90 cm; Pharmacia 
Fine Chemicals) and Bio-Gel P-2 200-400 mesh (1.6 x 90 cm; Biorad 
Laboratories) columns with 2 N acetic acid . 
High performance liquid chromatography (HPLC) - HPLC 
analysis was on a Model SP 3500B liquid chromatograph (Spectra-Physics) 
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equipped with a Model 770 spectrophotometric detector (Spectra-Phys~cs). 
A Spherisorb ODS reverse phase column (0.4 x 25 cm; 5 µm particle size; 
Phase Separations) was eluted isocratically for 40 min with 22% acetoni-
trile in 0.01 M ammonium acetate, pH 4.0, followed by a 20-min linear 
gradient from 22% to 80% acetonitrile in 0.01 M ammonium acetate, pH 4.0, 
and then isocratically for 5 min at 80% acetonitrile, A Partisil 
PXS 10/25 SCX cation exchange column (0.4 x 25 cm; Whatman) was eluted 
isocratically with 10% ethanol in 0.2 M ammonium acetate, pH 4.6. 
Immunoreactive chicken LH-RH was reconstituted in the starting HPLC 
buffer and eluted at a flow rate of 1.5 ml/min, 
Chymotrypsin-generated fragments of immunoreactive chicken 
LH-RH and synthetic mammalian LH-RH (described below ), and the synthetic 
fragment LH-RH (6-10), were eluted from the cation exchange column 
using the conditions described above. 
Cation exchange chromatography - Immunoreactive chicken 
LH-RH was reconstituted in 0.002 M ammonium acetate, pH 4.5, and 
eluted on a CM32 carboxymethyl cellulose column (1 x 18 cm; Whatman) 
with 0.002 M ammonium acetate for the initial 20 ml and then 0.06 M 
ammonium acetate, pH 4.5. 
Isoelectric focusing - Immunoreactive chicken LH-RH was 
reconstituted in 50 µl H20, and chromatofocused on polyacrylamide 
gel rods (0.4 x 7 cm) with either Ampholine pH 3.5 9 . 5 (1KB) or 
Pharmalyte pH 3-10 (Pharmacia Fine Chemicals ) plus Ampholine pH 
9-11 with a potential of 550 Vat 4°c for 2.5 h, Buffers used were 
0.01 M HEPES (Sigma) (upper reservoir) and 0 .01 M ethanolamine (BDH) 
(lower reservoir), Gels were sliced, and the slices were disrupted 
and eluted with 300 µl 0.2 N acetic acid: ethanol (1 1) for 16 h, 
Aliquots were assayed for LH-RH immunoreactivity. The pH was 
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determined on gels run in parallel, after slicing and addition of 0.45% 
NaCl. 
Radioimmunoassay of LH-RH 
LH-RH was measured as described by Hendricks et ai. (1975), 
with modifications. Synthetic mammalian LH-RH (Ayerst Laboratories) 
was used as standard. Synthetic mammalian LH-RH was labelled with 125r 
using the chloramine T method (Greenwood et ai., 1963) and purified 
on a CM32 carboxymethyl cellulose cation exchange column (1 x 20 cm; 
Whatman) eluted with 0.002 M ammonium acetate, pH 4,5, for the initial 
20 ml and then 0.06 M ammonium acetate, pH 4.5. Antisera were generated 
in rabbits against synthetic mammalian LH-RH. Antiserum 1076 was pro-
duced to LH-RH conjugated with Haliotis sp. haemocyanin by carbodiimide 
condensation (Hendricks et ai., 1975). Antisera 743 and 744 were 
generated against [Glu1]LH-RH conjugated with human serum albumin 
through predominantly Gl~1 by carbodiimide condensation (Schally et 
ai., 1980; gift from A. Arimura). Antiserum 422 was produced to LH-RH 
adsorbed on polyvinylpyrrolidone (Schally et ai., 1980; gift from 
A. Arimura). Antiserum R-42 was produced to LH-RH conjugated with 
bovine serum albumin by bis-diazotized-benzidine conjugation (Nett 
et al., 1973; gift from T.M. Nett and G.D. Niswender). Radioimmuno-
assay characteristics are given in Table 1. The cross-reactivity of 
' 
antisera 1076, 743, 744 and 422 with fragments and analogues of LH-RH 
is presented in Table 2; for antiserum R-42 see Nett et al. (1973) and 
Copeland et al. (1979). 
Immunoreactive chicken LH-RH was reconstituted in phosphate-
buffered saline containing gelatin (PBS-gel) (0.04 Mphosphate, 0.15 M 
NaCl, 0.01 M disodium ethylenediaminetetra-acetic acid and 0.015 M 




Final Half-maximal Limit of Intra-assay 
Antiserum dilution displacement sensitivity 
coefficient of 
(pg) (pg) variation 
(%) 
1076 1:100 , 000 15 , 7 <1.2 3 . 5 
743 1:30,000 23.1 1. 6 6 . 0 
744 1 : 25,000 217 . 0 6 . 0 5 . 6 
422 1:5 , 000 147 . 0 41.0 3 . 1 
R-42 1:200,000 13 . 1 <l. 2 5 . 5 
TABLE 2 
Cross-reactivity of four LH-RH antisera with fragments and 
analogues of LH-RH, expressed as percentage 
Ant iserum 
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0 . 4 0.5 0 . 3 26 pGlu Alo . Gly 
The cross-reactivities were calculated from the molar concentr-
ations of the fragments and analogues which decreased the binding 
of 125I-LH-RH to the antisera by 50%. Some of these data are 
from Hendricks et al. (1975) and Millar et al. (1978). 
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dilutions in duplicate, us ing the five antisera (1076, 743, 744, 422 
and R-42) directed toward specific regions of the LH-RH molecule. 
Appropriate antisera were used in assaying chromatographic column 
eluates andsamples from the enzymic inactivation and chemical modific-
ation experiments . 
Enzymic inactivation experiments 
One to 20 ng immunoreactive chicken LH-RH was digested with 
2 µg of enzyme in a total volume of 0.1 - 1 ml buffer . The digestions 
with subtilisin (Sigm~), pronase P (Sigma) , thermolysin (Sigma) , 
carboxypeptidase A (Boehringer Mannheim) and carboxypeptidase B (Merck) 
were carried out in 0 . 02 M ammonium acetate, pH 7.5. Digestions with 
neuraminidase (Sigma), beta-glucuronidase (Miles) and papain (BDH) 
were in 0 . 02 M ammonium acetate, pH 5.0. Digestions with pyrogluta-
mate aminopeptidase (Boehringer Mannheim) (100 µg enzyme) and protease 
from S. aureus VB strain (Miles) were in 0 . 05 M potassium phosphate , 
pH 7 . 8 . Digestion with ~lkaline phosphatase (Miles) was in 0 . 02 M 
ammonium acetate , pH 10 . 0. Digestion with pepsin (Sigma) was in 0 . 01 N 
HCl . Digestion with trypsin (2X recrystallised; BDH) was in 0 . 01 M 
ammonium acetate, pH 8.2. Digestion with chymotrypsin (Seravac) was in 
0 . 01 M ammonium acetate containing 0.002 M ethylenediaminetetra-acetic 
acid, pH 8.4 . Digestions with aminopeptidase M (Boehringer Mannheim) 
and aminopeptidase K (Sigma) were in 0 . 02 M ammonium acetate , pH 8.0. 
Digestion with post-proline-cleaving enzyme (gift from K. Bauer) was 
in 0.1 M phosphate containing 0 . 001 M ethylenediaminetetra-acetic acid 
and 0.002 M dithiothreitol , pH 7.4. Digestions were carried out in 
0 
triplicate at 37 C for 24 h, and terminated by boiling for 15 min. 
All enzymes were shown to be active under the conditions 
employed by reaction with appropriate substrates containing sensitive 
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cleavage points (synthetic mammalian LH-RH, analogues and fragments of 
LH-RH, and other peptides of known ·structure). Control samples of 
inactivated and active enzyme alone, and substrate with inactivated 
enzyme, were included in the studies. Samples were lyophilised, recon-
stituted in PBS-gel, and assayed for LH-RH immunoreactivity with 
appropriate antisera. For example, samples digested with post-proline-
cleaving enzyme were assayed with antiserum R-42 to show whether there 
was cleavage post proline, and with antiserum 743 to show that the frag-
ment LH-RH (1 - 9) remained intact. Chymotrypsin-digested samples for 
cation exchange HPLC analysis were lyophilised and reconstituted in 
HPLC buffer. 
Chemical modification experiments 
One to 10 ng immunoreactive chicken LH-RH was used in all 
reactions, which were carried out in triplicate, In the reaction with 
Pauly's reagent, 20 µl diazotized sulfanilic acid (10 µl 1% sulfanilic 
acid in l N HCl plus 10 µl 0.5% aqueous sodium nitrite) was reacted 
with substrate in 100 µl H20 at 21°c for 30 min, followed by addition 
of 20 ·µ1 5% Na2C03, In the reaction with ninhydrin, 10 µl 2% ninhydrin 
in ethanol : 4 M sodium acetate, pH 5.0, (1: 3) was reacted with 
0 
substrate in 100 µl H20 at 37 C for 24 h. For the reaction with 
Sakaguchi reagent, 100 µl of 0.01% a-Naphthol and 5% urea in ethanol 
_was added to substrate in 100 µl H20 , followep by addition of 50 pl 5% 
aqueous sodium hypobromite. The reaction mixture was incubated at 21°c 
for 24 h. Two mg of 1,2-cyclohexanedione (Koch-Light Laboratories) was 
reacted with substrate in 250 µl 0.2 M aqueous KOH at 21°c for 24 h, 
Two mg of benzil (Sigma) was reacted with substrate in 250 µl 0.2 M KOH 
in 80% ethanol, Eighteen µg of nitrophenylsulphenylchloride (Sigma) 
was reacted with substrate in 250 µl 50% acetic acid at 21°c for 24 h. 
0.17 M ethoxyformic anhydride (Sigma) was reacted with substrate in 
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0 
250 µl H2 0 at 21 C for 24 h. 
All chemicals were shown to be active under the conditions 
employed by reaction with appropriate substrates containing sensitive 
amino acid residues (synthetic mammalian LH-RH, analogues and fragments 
of LH-RH, and other peptides of known structure). Control samples of 
reagents alone, and substrate alone, were included in the studies . 
Samples were lyophilised, reconstituted in PBS-gel containing an excess 
of the amino acid residue which is specifically modified by the particul-
ar chemical, and assayed for LH-RH irnmunoreactivity with appropriate 
antisera. For example, samples treated with .Sakaguchi reagent were 
assayed with antiserum 1076 to show whether there was modification at 
Args, and with antiserum R-42 to show that the chemical did not alter the 
peptide in a nonspecific way. 
Comparison of natural chicken LH-RH with synthetic [Gln8]LH-RH 
[Gln8]LH-RH was synthesised by the solid-phase method of 
Merrifield (1963) and .its structure was verified by chemical analyses 
(see section 4 . 3). The chromatographic and immunological properties 
of synthetic [Gln8]LH-RH were compared wi~h those of natural chicken 
LH-RH, using the methods described above . 
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2,4 RESULTS 
Partial purification of chicken hypothalamic LH-RH 
The hypothalamic extract contained 128,3 mg total peptide 
and 998 ng immunoreactive LH-RH (antiserum 422). Non-immunoreactive 
peptides were eluted from the affinity column with 0.5 M ammonium 
acetate (Fig. 1) and immunoreactive LH-RH was then eluted with 1.5 N 
acetic acid (Fig. 1), Total yield was 969 ng immunoreactive· LH-RH 
(antiserum 422) in 1,8 mg total peptide, representing a 70-fold 
purification. 
Chromatographic analyses 
Sephadex G-25 (Fig. 2A) ' and Bio-Gel P-2 (Fig. 2B) chromato-
, graphy of 6 M urea-treated immunoreactive chicken LH-RH revealed a 
single peak of immunoreactivity which co-eluted with the synthetic 
mammalian decapeptide, indicating a similarity in molecular size. 
Since a single immunoreactive peak was obtained when Sephadex G-25 
column fractions were assayed with both the middle - directed antiserum 
1076 and the NH2- and COOH-terminus-directed antiserum R-42 (Fig. 2A), 
it would appear that higher molecular weight forms of chicken LH-RH 
(if present) do not cross-react with these antisera. Reverse phase 
HPLC of immunoreactive chicken LH-RH revealed a single peak of immuno-
reactivity eluting earlier than ·synthetic mammalian LH-RH (Fig. 3A). 
In cation exchange HPLC (Fig. 3B) and CM32 carboxymethyl cellulose 
chromatography (Fig. 3C) immunoreactive chicken LH-RH .eluted earlier 
than synthetic mammalian LH-RH, indicating that the chemical structure 
or chicken LH-RH is different and the peptide is less positively charged. 
Isoelectric focusing confirmed that chicken LH-RH (pI = 7,3) is less 
basic than synthetic mammalian LH-RH (pl= 9,1) (Fig, 4A), 
- 2(_ -
,.... 
0.5 M 1.5 N 1.0 M E NH4Ac 1 HAc ! NH4Ac - 8 0) 
........_ C 
2.0 -•-•-•-•-•-•-•-•-•-•-•-•-•-•-• ,• -• 100 '---E ' ' ,-•' ' :I: - ' I 6 I a: 0) I 
E f 
I 
I 80 :I: '-' I -' 1.5 I I I 
I 4 I UJ UJ I I > Q I 60 I I I I t-t- I I I I u a. 1.0 I I 2 ·-·-· <t UJ UJ a. 40 a: 
0 
-' z 0 
~ 0 .5 :::> ~ 
0 20 ~ t-
D 0 0 El 
0 100 200 300 400 500 
COLUMN ELUATE (ml) 
FIGURE l 
Affinity chromatography of immunoreactive chicken LH-RH on a 
Sepharose-anti-LH-RH 1076 column. Fractions were assayed for LH-RH 
i mmunoreactivity with antiserum 422 , and for Falin- Lowry peptide 
using bovine serum albumin as standard . NH 4 Ac , ammonium acetate ; 
HAc , acetic acid . 
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FIGURE 2 
Gel filtration chromatography of immunoreactive chicken LH-RH and 
synthetic mammalian LH-RH. Void volume (Vo) and salt volume (Vs) 
are marked with arrows . A, Sephadex G-25 chromatography: 
Immunoreactive chicken LH-RH in fractions from a single column 
rW1 was measured with both antiserum 1076 ·( 36 ng ; recovery was 
89%) ( 0- - - - -0 )and antiserum R-42 (118 ng; recovery was 92%) 
( • •). Synthetic mammalian LH-RH in fractions was measur-
ed with antiserum 1076 (30 ng; recovery was 114%) (D·-·-·---~). 
B, Bio-Gel P-2 chromatography. Immunoreactive chicken LH-RH in 
fractions was measured with antiserum R-42 (143 ng; recovery was 
87%) (e e). Synthetic mammalian LH-RH in fractions was 
measured with antiserum 1076 (123 ng; recovery was 97%) 
( 0-·- ·-·-0). 
,, 
FIGURE 3 
Reverse phase HPLC, cation exchange HPLC and CM32 carboxymethyl 
cellulose chromatography of immunoreactive chicken LH-RH, synthetic 
mammalian LH-RH and synthetic [Gln8]LH-RH. Immunoreactive chicken 
LH-RH (e e) and synthetic [Gln8]LH-RH (0------0) in fract-
ions was measured with antiserum R-42, Synthetic mammalian LH-RH 
(0-·-·-·-·--0) in fractions was measured with antiserum 1076. A, re-
verse phase HPLC separation of immunoreactive ch_icken LH-RH (20 ng; 
recovery was 91%), synthetic mammalian LH-RH (20 ng; recovery was EB%) 
and synthetic [GlnB]LH-RH (20 ng; recovery was 91%). Elution peaks of 
synthetic LH-RH analogues (detected by UV absorbance at 280 nm) are 
marked with arrows: 1 LH-RH-OH, 2 [Lys 8]LH-RH, 3 [Ala9]LH-RH, 
4 [Thr4]LH-RH, 5 [Phe7]LH-RH, 6 [Ile6]LH-RH, B, cation exchange HPLC 
separation of immunoreactive chicken LH-RH (7,5 ng; recovery was 87%), 
synthetic mammalian LH-RH (11 ng; recovery was 89%) and synthetic 
[GlnB]LH-RH (18.5 ng; recovery was 95%). C, CM32 carboxymethyl 
cellulose chromatography of immunoreactive chicken LH-RH (14 ng; re-
covery was 81%) and synthetic mammalian LH-RH (14 ng; recovery was 
98%). In each of these chromatographic systems the relative elution 
volumes of chicken LH-RH, synthetic mammalian LH-RH and synthetic 
[Gln8]LH-RH were confirmed by chromatographing the three peptides 
separately and in combination in different runs. When column fract~ 
ions were assayed with both antiserum R-42 and 1076, only a single 
immunoreactive peak was obtained; the elution volume ~as the same as 
those described above. 
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Isoelectric focusing of immunoreactive chicken LH-RH, synthetic 
mammalian LH-RH and synthetic [Gln8]LH-RH on polyacrylamide gel 
rods. A, immunoreactive chicken LH-RH (2.4- ng; recovery was 
69%) (G e) and synthetic mammalian LH-RH (15 ng; recov-
ery was Bl%) (0-·-·-·-·-·0) eluted with Pharmalyte pH 3-10 plus 
Ampholine pH 9-11. Gel slices were assayed with antiserum 1076. 
The pl of synthetic mammalian LH-RH is lower than the theoretic-
al value, because high pH conditions were not produced when 
using the pH range suitable for chicken LH7RH. B, irnrnuno-
reactive chicken LH-RH spiked with synthetic [Gln8]LH-RH (7.5 ng 
each; recovery was 79%) (e e) eluted with Ampholine 
pH 3.5-9.5. Gel slices were assayed with antiserum R-42. 
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Radioimmunoassay employing different antisera 
For effective binding, antisera 1076 and 743 require residues 
within the region Trp 3 to Pro 9 , antiserum 744 requi~es residues ArgB to 
/ 
Gly10-NH2, and antisera R-42 and 422 require both NH2- and COOH-termini 
and tolerate certain alterations in the middle of the decapeptide (Fig, 5), 
In radioimmunoassays employing antisera R-42 and 422, immuno-
reactive chicken LH-RH yielded displacement curves parallel to those of 
synthetic mammalian LH-RH (Fig, 6). However, in radioimmunoassays 
employing antisera 1076, 743 and 744 the immunoreactive chicken LH-RH 
displacement curves were clearly nonparallel to those of synthetic 
mammalian LH-RH, indicating nonidentity of chicken LH-RH with the mammal-
ian peptide in those regions of the molecule which are required for 
binding by these antisera (Fig, 6). Furthermore, the relative quantit-
ation of immunoreactive chicken LH-RH varied in radioimmunoassays employ-
ing the different antisera, Antisera R-42 and 422 ,consistently yielded 
higher values than did the other antisera (Fig. 6). Considering the 
regions of the LH-RH molecule which are required forhindingby these 
antisera (Fig. 5_), these data are consistent with an alteration in 
chicken LH-RH at position eight (arginine). 
The possibility that nonparallelism was caused by contamin-
ants in the affinity-purified immunoreactive chicken LH-RH (such as 
peptidases and substances binding LH-RH) was e~cluded by the demonstr-
ation that 12 5I-LH-RH was neither degraded nor bound by the affinity-
purified material. Moreover, when the affinity-purified immunoreactive 
chicken LH-RH was chromatographed in the systems described above and the 
column fractions assayed with different antisera (some data are not shown), 
only a single immunoreactive peak was obtained and the same relative 
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Regions of the LH-RH molecule which are essential for full 
immunoreactivity with each of five antisera, determined from 
cross-reactivity studies ( see Table 2 and Copeland et aZ., 
1979). LH-RH is represented in linear form here; the NH2 - and 
COOH-terrnini are closely apposed in the three-dimensional 
conformation of the molecule (Momany, 1978). 
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FIGURE 6 
Comparative displacement of 125I-LH-RH from antisera 1076, 743, 
R-42 and 744 by immunoreactive chicken LH-RH (G •), 
synthetic mammalian LH-RH ( X X) and synthetic 
[Gln8]LH-RH (0 O). Quantitation of imrnunoreactive 
chicken LH-RH ( •) and synthetic [Gln8]LH-RH ( 0) with the 
different antisera is expressed relative to the value obtained 
with antiserum R-42 . The displacement curve of imrnuno-
reactive chicken LH-RH in radioimrnunoassay with ~ntiserum 422 
was parallel to that of synthetic mammalian LH-RH; and quantit-
ation was identical to that obtained with antiserum R-42 (data 
not shown). 
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that the different quantitation with various antisera is due to different 
·interactions with the same molecule·. 
Enzymic inactivation experiments 
The effect of various enzymes on the immunoreactivity of 
chicken LH-RH and synthetic mammalian LH-RH is shown in Table 3. Immuno-
reactivity of both substrates was unaffected by alkaline phosphatase, 
neuraminidase, beta-glucuronidase, pepsin, trypsin, carboxypeptidase 
A and B, and aminopeptidase Mand K. However, incubation with papain, 
subtilisin, pronase P, thermolysin, chymotrypsin, post-proline-cleaving 
enzyme, protease from S. aureus VS strain, and pyroglutamate amino-
peptidase reduced or abolished the immunoreactivity of both substrates. 
Immunoreactivity of post-proline-cleaving enzyme-treated chicken and 
mammalian LH-RH was unaltered by carboxypeptidase A and B. Cation 
exchange HPLC of the chymotrypsin-generated fragments of immunoreact-
ive chicken LH-RH and synthetic mammalian LH-RH revealed no peak of 
immunoreactivity (antiserum 744) of fragment (6-10) of chicken LH-RH, 
while chymotrypsin-generated fragment (6-10) of synthetic mammalian 
LH-RH co-eluted with the synthetic fragment LH-RH (6-10), indicating 
that chicken LH-RH differs from synthetic mammalian LH-RH in the 
region Gly6 to Gly10-NH2. 
Chemical modification experiments 
The effect of chemical modification ' of specific amino acids 
on the immunoreactivity of chicken LH-RH and synthetic mammalian LH-RH 
is shown in Table 4. Immunoreactivity of both substrates was unaffect-
ed by treatment with ninhydrin, while treatment with Pauly's reagent 
and nitrophenylsulphenylchloride reduced the immunoreactivity of both 
substrates. The results from chemical modification with Sakaguchi 












































































































Control samples showed enzymes did not interfere in the radioimmunoassay. 




Effect of chemical modification of specific amino acids on the 
immunoreactivity of chicken LH-RH and synthetic mammalian LH-RH 
Antiserum Percentage residual immunoreactive 
a used in 
LH-RH 
reagent 
radioimmunoassay Chicken Synthetic 
LH-RH mammalian 
LH-RH 
Pauly's reagent 1076 0 0 
Ninhydrin R-42 98 88 
Nitrophenylsulphenyl-
chloride 1076 19 6 
R-42 20 19 
744 
b 100 
a Data on reagents which were nonspecific in their modification or which 
interfered in the radioimrnunoassay have been excluded. 
b Level of chicken LH-RH (before and after treatment) was below the 
sensitivity limit of the radioimmunoassay with antiserum 744. 
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inconclusive. Interference by these reagents in the LH-RH radio-
immunoassay did not allow meaningful interpretation of the data. 
Comparison of natural chicken LH-RH with synthetic [Gln8]LH-RH 
Synthetic [Gln8]LH-RH was shown to have identical chromato-
graphic and immunological properties to natural chicken LH-RH. The 
retention times of synthetic [Gln8]LH-RH and natural chicken LH-RH 
were the same under identical reverse phase (Fig. 3A) and cation 
exchange (Fig. 3B) HPLC chromatographic conditions, The synthetic 
peptide was indistinguishable from the natural material in isoelectric 
focusing (Fig. 4B). In radioimmunoassays employing four region-specific 
antisera, the immunological properties of synthetic [Gln8]LH-RH were 
very similar to those of natural chicken LH-RH in terms of slope of 
displacement curves and relative quantitation with diffepent 
antisera (Fig. 6). 
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2.5 DISCUSSION 
Gel filtration chromatography indicated a single species of 
immunoreactive chicken LH-RH, identical in size to synthetic mammalian 
decapeptide LH-RH, However, from reverse phase and cation exchange HPLC, 
CM32 carboxymethyl cellulose chromatography and isoelectric focusing it 
is apparent that immunoreactive chicken LH-RH is not identical to 
synthetic mammalian LH-RH, the chicken peptide being less positively 
charged as previously demonstrated (Jackson, 1971a, 1971b; King and 
Millar, 1979a, 1980, 1981a; Hattori et al., 1980). 
The structural difference in chicken LH-RH was investigated 
by radioimmunoassay employing region-specific antisera. The parallelism 
in ·the displacement curves of immunoreactive chicken LH-RH and synthetic 
mammalian LH-RH in radioimmunoassays with the NH2- and COOH-terminus-
directed antisera R-42 and 422, together with the higher quantitation 
with these antisera, suggests that the chicken LH-RH molecule has an 
NH2-terminal pGlu1 and a COOH-terminal Gly1D-NH2 as in synthetic mammal-
ian LH-RH. Nonparallel displacement curves were yielded in radioimmuno-
assays employing the middle-directed antisera 1076 and 743, and the 
COOH-terminus-directed antiserum 744, 'and quantitation was much lower 
with these antisera. It is evident, then, that chicken LH-RH differs 
from synthetic mammalian LH-RH in that region of the molecule which 
antisera 1076, 743 and 744 require for binding but which is not required 
for binding by antisera R-42 and 422, i.e. amino acid residue eight 
(arginine). Significantly , antiserum 744 which requires residues Arg8 
to Gly10-NH2 for binding gave the lowest quantitation and the greatest 
deviation from parallelism. Alteration in a remote region of the LH-RH 
molecule could also conceivably cause conformational change in LH-RH at 
Arg8 , but ·quantitation with antisera binding regions remote from Arg8 
was not low. 
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Results from enzymic inactivation and chemical modification 
studies were consistent with an amino acid substitution in position eight 
(arginine). The possibility that the structural difference in chicken 
LH-RH represents a post-translational alteration such as phosphorylation 
of His2 , Ser4 or Tyr 5, glycosylation of Ser4 , or sulphation of Tyrs, was . 
excluded due to the lack of effect of alkaline phosphatase, neuraminidase 
and beta-glucuronidase (containing aryl sulphatase). Studies with 
proteolytic enzymes also yielded information on the structural homology 
and differences -between chicken LH-RH and mammalian LH-RH, The fragment 
LH-RH(6-10) was generated from synthetic mammalian LH-RH by chymotrypsin 
digestion, and shown to elute at 13.5 ml in cation exchange HPLC. Such 
a fragment was not detected (antiserum 744) among the chymotrypsin-
generated fragments of immunoreactive chicken LH-RH, again indicating 
that the structural difference in the chicken peptide resides in the 
region Gly6 to Gly1 D-NH2. Inactivation by Pauly's reagent and nitro-
phenylsulphenylchloride indicates the presence of Trp3 and possibly 
also His2 and Tyr5 , supporting our observation that the structural 
difference in chicken LH-RH is in the COOH-terminal half of the molecule. 
The lack of effect of aminopeptidase, carboxypeptidase and ninhydrin, 
and inactivation by pyroglutamate aminopeptidase, confirms that chicken 
LH-RH has a blocked NH2- and COOH-terminus in accordance with the observ-
ation that antisera R-42 and 422, which have an absolute requirement for 
pGlu1 and Gly10-NH2, bind chicken LH-RH avidly, The presence of proline 
at position nine is indicated by inactivation of chicken LH-RH by 
post-praline-cleaving enzyme (immunoreactivity was abolished when 
measuring with antiserum R-42 but not with antiserum 743), and by the 
lack of effect of carboxypeptidase A and Bon post-proline-cleaving 
enzyme-treated chicken LH-RH. 
I 
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The foregoing data provide firm evidence that chicken LH-RH 
differs from mammalian LH-RH by an amino acid substitution at position 
eight (arginine). Attempts to confirm the absence of Arg8 in chicken 
LH-RH by attempting chemical modification (Sakaguchi reagent, 1,2-cyclo-
hexanedione and benzil) were unsuccessful. Ghicken LH-RH is clearly 
less positively charged than the mammalian peptide (as shown by chromato-
graphy), and the isoelectric point of 7.3 (Fig. 4) is compatible with a 
neutral amino acid substitution for Arg8 (Greenstein and Winitz, 1961) . 
. Structural studies on mammalian LH-RH have shown that the side chain of 
Arg8 is in close vicinity to the side chains of His2 and Tyrs, and that 
these side chains are linked by hydrogen bonds and form a combined unit 
important for biological action (Shinitzky and Fridkin, 1976). A likely 
neutral amino acid substitution at position eight compatible with these 
structural requirements is glutamine. Moreover, of the neutral amino 
acids, the probability of a glutamine/arginine interchange is consider-
able (Dayhoff et aZ., 1972). 
In view of these firm indications that chicken hypothalamic 
LH-RH differs from the mammalian hypothalamic peptide by the substitut-
ion of glutamine for arginine at position eight, we synthesised 
[Gln8]LH-RH for comparison with the natural material. Synthetic 
[GlnB]LH-RH was found to have identical chromatographic and immuno-
logical properties to the natural chicken peptide in chromatographic 
systems capable of separating a wide range of LH-RH analogues (see 
Fig. 3A). Moreover, we have also established that synthetic [Gln8]LH-RH 
and natural chicken LH-RH have identical potency in stimulating 
luteinizing hormone release from dispersed chicken anterior pituitary 
cells and cultured ovine anterior pituitary cells (see section 4.4). 
We propose, therefore, that the structure of chicken hypoth~lamic 
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LH-RH is : 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-GZn-Pro-Gly-NH2. 
The low biological activity of mammalian LH-RH in birds and 
fish may be due to a structural difference at residue eight of LH-RH 
in these vertebrate classes. Studies have, therefore, been initiated 
to investigate the gonadotropin-releasing activity and receptor binding 
characteristics of synthetic [Gln8]LH-RH in submammalian vertebrates. 
3.0 ISOLATION AND CHARACTERISATION OF CHICKEN HYPOTHALAMIC 
LUTEINIZING HORMONE-RELEASING HORMONE 
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3.1 SUMMARY 
Avian luteinizing hormone-releasing hormone (LH-RH) has 
been isolated from 249,000 chicken hypothalami and shown to differ 
structurally from mammalian hypothalamic LH-RH. Purification was 
achieved by acetic acid extraction, anti-~H-RH affinity chromato-
graphy, and cation exchange and reverse phase high performance liquid 
chromatography (HPLC). The isolated peptide eluted as a single peak 
on reverse phase HPLC. Acid hydrolysis of the peptide yielded 
integral molar ratios of amino acids and a composition identical 
to that of mammalian decapeptide LH-RH, except for the presence of 
an additional glutamic acid residue and the ~bsence of arginine. 
The isoelectric point of chicken LH-RH (7.3) is consistent with the 
glutamic acid representing a glutamine residue. We therefore syn-
thesised [Gln8]LH-RH, and established that it has identical chromato-
graphic properties to natural chicken LH-RH. These studies indicate 
that the , structure of chicken hypothalamic LH-RH is: 
pGlu-His-Trp-Ser-Tyr-Gly-Leu-GZn-Pro-Gly-NH2, 
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3.2 INTRODUCTORY STATEMENT 
The decapeptide LH-RH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-
Pro-Gly-NH2), origina~ly isolated from porcine hypothalami (Matsuo 
et al., 1971a) and later synthesised (Matsuo et al., 1971b), appears 
to have lower gonadotropin-releasing activity in submammalian verte-
brates than in mammals. Crude hypothalamic extracts from birds, 
reptiles, amphibians and fish, however, contain significant gona-
dotropin-releasing activity, and LH-RH-like immunoreactivity has been 
demonstrated in the hypothalamus of these vertebrates by radioimmuno-
assay and immunocytochemistry (for reviews, see Ball, 1981; Jackson, 
1981; King and Millar, 1981a). We have shown that immunoreactive 
amphibian hypothalamic LH-RH is identical to the mammalian deca-
peptide in chromatographic properties and in its interaction with 
region-specific LH-RH antisera, whilst immunoreactive LH-RHs from 
avian, reptilian, and piscine hypothalami are structurally different 
from mammalian hypothalamic LH-RH (King and Millar, 1979a, 
1980, 1981a). These structural differences of LH-RH-like peptides 
in submammalian vertebrates have not been determined. We have 
characterised chicken hypothalamic LH-RH using partially purified 
material, and established that the peptide differs from mammalian 
hypothalamic LH-RH at position eight, arginine being substituted by 
glutamine (see section 2). This section describes the isolation and 
amino acid composition of homogeneously pure chicken hypothalamic 
LH-RH, and confirms that glutamine substitutes for the arginyl 
residue at position eight in mammalian hypothalamic LH-RH. 
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3.3 MATERIALS AND METHODS 
Extraction 
Fragments of 249,000 chicken (Gallus domestiaus) hypo-
thalami consisting of the median eminence and pituitary stalk were 
dissected, frozen on dry ice, and lyophilised. Three batches of 
lyophilised hypothalami were defatted with petroleum ether (40-60°c) 
at 4°C, and extracted with 2 N acetic acid at 4°c using an ultra-
turrax homogeniser and then a glass homogeniser with a teflon pestle. 
0 The homogenate was centrifuged at 18,000 g for 1 hat 4 C, and the 
insoluble residue was re-extracted four times. The supernatants 
from the five extractions were pooled, and aliquots were taken for 
radioimmunoassay and for total peptide determination using bovine 
serum albumin as standard (Lowry et al., 1951). The supernatant 
extract was then lyophilised. 
Affinity chromatography 
Antiserum 1076 was generated in a rabbit against synthetic 
mammalian LH-RH conjugated with Haliotis sp. haemocyanin by carbodi-
imide condensation (Hendricks et al., 1975). The antiserum requires 
residues within the region Trp3 to Pro9 of synthetic mammalian LH-RH 
for effective binding (Millar et al., 1978; Table 2). The gamma 
globulin fraction of antiserum 1076 obtained after ammonium sulphate 
precipitation was immobilised on cyanogen bromide-activated Sepharose 
4B (Pharmacia Fine Chemicals) at a concentration of 0.3 ml antiserum 
equivalents of gamma globulin per g of Sepharose. The retention 
c,apacity of the Sepharose-anti-LH-RH 1076 column (3.5 x 26 cm) was 
8.3 µg of synthetic mammalian LH-RH. Due to this limited retention 
capacity it was necessary to process the supernatant extract in ten 
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separate runs. The lyophilised super natant extract was reconstituted 
in 0.5 M ammonium acetate, pH 7.0, and cycled through the column for 
6 to 8 h . The column was washed with 0.5 M ammoniu,~ acetate to remove 
unbound peptides, and the bound material was eluted with 1.5 N acetic 
acid. Aliquots of fracti~ns were taken for radioimmunoassay and for 
Folin-Lowry total peptide determination. Fractions with LH-RH immuno-
reactivity from all ten runs were pooled and lyophilised. 
High performance liquid chromatography (HPLC) 
Two different systems were used on a Model SP 3500B liquid 
chromatograph (Spectra-Physics) equipped with a Model 770 spectro-
photometric detector (Spectra-Physics). The first HPLC system con-
sisted of a Partisil PXS 10/25 SCX cation exchange column (0.4 x 25 cm; 
What~an) and a mobile phase of 10% ethanol in 0.05 M ammonium acetate, 
pH 5.6. ·Lyophilised affinity-purified i mmunoreactive LH-RH was recon-
stituted in HPLC buffer and eluted in twelve separate runs. Flow rate 
was 1.6 ml/min . Absorbance at 280 nm was monitored at 0.2 units full 
scale . Fractions of 1 . 6 ml were collected and aliquots of 5 µl were 
taken for radioimmunoassay . Immunoreactive fractions from all twelve 
runs were pooled and lyophilised. The second HPLC system consisted of a 
Spherisorb ODS reverse phase column (0 . 4 x 25 cm; 5 µm particle size; 
Phase Separations) and .a mobile phase of 22% acetonitrile in 0.01 M 
ammonium acetate , pH 4.0. Lyophilised immunoreactive LH-RH from the 
cation exchange HPLC system was reconstituted in HPLC burfer and eluted 
in four separate runs. Flow rate was 1,5 ml/min . Absorbance at 280 nm 
was monitored at 0.04 units full scale. Fractions of 1.5 ml were 
collected and aliquots of 5 µl were taken for radioimmunoassay. Immuno-
reactive fractions from all four runs were pooled and lyophilised . 
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Radioimmunoassay of LH-RH 
LH-RH was measured as described in section 2.3. Antiserum 
R-42 (gift from T.M. Nett and G.D. Niswender) was used throughout the 
study since it yields chicken hypothalamic LH-RH displacement curves 
parallel to that of mammalian LH-RH and apparently estimates chicken 
LH-RH near quantitatively (see sections 2.3 and 2,4). For effective 
binding, the antiserum requires both NH2- and COOH-termini and tolerates 
certain alterations in the middle of the decapeptide (Nett et aZ., 1973; 
Copeland et al., 1979). 
Lyophilised aliquots of extracts and chromatographic column 
fractions were reconstituted in phosphate-buffered saline containing 
gelatin (0.04 M phosphate, 0.15 M NaCl, 0.01 M disodium ethylene-
diaminetetra-acetic acid and 0.015 M NaN3 , pH 7.0, with 0.1% gelatin) 
and assayed for LH-RH immunoreactivity. 
Amino acid analysis . 
Purified imrnunoreactive LH-RH (0.5 µg) was hydrolysed in 
100 µl constant boiling 6 N HCl containing 2% thioglycolic acid in 
0 sealed evacuated tubes at 110 C for 16 h. The hydrolysate was lyo-
philised, reconstituted in 0.15 M lithium citrate buffer, pH 2.2, and 
subjected to amino acid analysis (Beckman Instruments Model 121-MB). 
Comparison of natural chicken LH-RH with synthetic [Gln8]LH-RH 
[Gln8]LH-RH was synthesised by the solid-phase method of 
Merrifield (1963) and its structure was verified by chemical analyses 
(see sections 4.3 and 4.4). The chromatographic properties of synthetic 
[Gln8]LH-RH on cation exchange and reverse phase HPLC were determined 
using the methods described above for the purification of natural 
chicken LH-RH. The isoelectric points of natural chicken LH-RH and 
- 46 -
synthetic [Gln8]LH-RH were determined on polyacrylamide gel rods as 
described in section 2 . 3 . 
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3.4 RESULTS 
Immunoreactive chicken hypothalamic LH-RH was purified two 
' million-fold using the scheme outlined in Table 5. The hypothalamic 
acetic acid extract contained 7.5 g total peptide and 33.7 µg immuno-
reactive LH-RH. In affinity chromatography, non-immunoreactive 
peptides were eluted with 0.5 M ammonium acetate and immunoreactive 
LH-RH was then eluted with 1,5 N acetic acid (Fig. 7). The affinity-
purified immunoreactive LH-RH was subjected to cation exchange HPLC 
which revealed a major peak of immunoreactive LH-RH at 7 - 8 min 
(11.2 - 12.8 ml) and an earlier-eluting minor immunoreactive peak at 
4 min (6.4 ml) (Fig. 8). The major immunoreactive LH-RH peak was further 
purified by reverse phase HPLC. A single peak of immunoreactive LH-RH 
co-eluted with a single sharp absorbance peak at 23 - 24 min (34.5 -
36.0 ml) (Fig. 9), indicating that the isolated peptide was essentially 
I 
pure. 
The LH-RH was homogeneous, as judged by amino acid analysis 
(Table 6) demonstrating integral molar ratios of amino acids. The total 
amount of LH-RH peptide determined by amino acid analysis (0.48 µg) 
agreed closely with the value obtained by radioimmunoassay (0.51 µg) of 
the same material. The. amino acid composition, determined after acid 
hydrolysis, was : Ser 1, Glu 2, Pro 1, Gly 2, Leu 1, Tyr l,Trp 1 and 
His 1 (Table 6). 
The chromatographic properties of natural chicken LH-RH and 
synthetic [G1n 8]LH-RH were identical on cation exchange and reverse 
phase HPLC, and their isoelectric points were the same (Table 7). 
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TABLE 5 
Summary of purification scheme· for chicken hypothalamic LH-RH 
Dry Total Immuno- Recovery of 
Purification step weight peptide reactive LH-RH at each 
LH-RH step 
(g) (mg) (µg) (%) 
Lrophilised hypothalami 103 . 3 57,120.0 
2 N acetic acid extract 22 . 2 7,461.0 33.7 100 
Affinity chromatography 0.100 36.2 24,4 73 
Cation exchange HPLC 19.5 80 
Reverse phase HPLC 0.016a 17.4 90 
a 





































































Affinity chromatography of immunoreactive chicken LH-RH on a 
Sepharose-anti-LH-RH 1076 column. Aliquots of fractions were assay-
ed for LH-RH immunoreactivity with antise~um R-42, and for Folin-
Lowry peptide using bovine serwn albumin as standard . NH4 Ac , 
ammonium acetate; HAc, acetic acid. One of ten affinity runs is 
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FIGURE 8 
Cation exchange HPLC separation of a·ffinity-purified immune-
reactive chicken LH-RH using 10~ ethanol in 0.05 M ammonium 
acetate, pH 5.6. Aliquots of fractions were assayed for 
LH-RH immunoreactivity with antiserum R-42 . Absorbance at 
280 nm was recorded at a setting of 0.2 units full scale. 
One of twelve cation exchange HPLC runs is shown here; 
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FIGURE 9 
Reverse phase HPLC separation of cation exchange HPLC-purifi-. . 
ed immunoreactive chicken LH-RH using 22% acetonitrile in 
0.01 M ammonium acetate, pH 4.0. Aliquots of fractions were 
assayed for LH-RH immunoreactivity with antiserum R-42. Ab-
sorbance at 280 nm was recorded at a setting of 0.04 units 
full scale. One of four reverse phase HPLC runs is shown 






Amino acid composition of acid hydrolysate 
of chicken hypothalamic LH-RH 
Amino acid 
nmol/0.5 µg ratio a
 
0.44 0.92 
Glutamic acid 1.00 2.08 
Praline o .. 53 1.10 
Glycine 0.99 2.06 
Leucine 0.48 LOO 
Tyrosine 0.46 o. 96 
Tryptophan 0.47 0.98 











Molar ratios of amino acids were normalised to 1.0 for Leu. 
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TABLE 7 
Comparison of the chromatographic properties of natural chicken 
LH-RH, synthetic [Gln8]LH-RH and synthetic mammalian LH-RH 
Elution position 
Chromatographic Natural Synthetic Synthet'ic 
system chicken [Gln8]LH-RH mammalian 
LH-RH LH-RH 
Cation exchange HPLC 7 7 >20 
(min) 4.2a 4.2a 8.5a 
Reverse phase HPLC 24 24 >40b 
(min) 
Isoelectric focusing 7.3c 7.0d > 9.lc 
a 
b 
(pl) > 8.9d 
Eluted with 10% ethanol in 0.2 M ammonium acetate, pH 4.6. 
Synthetic mammalian LH-RH did not elute in a 40-min isocratic run of 
22% acetoni trile in O. OlM ammonium acetate, p_H 4. 0, but eluted at 
53 min when this was followed by a 20-min linear gradient of 22% to 
80% acetonitrile in 0.01 M ammonium acetate, pH 4.0. 
c . Ampholytes used were Pharmalyte pH 3-10 and Ampholine pH 9-11. 
d Ampholyte used was Ampholine pH 3.5-9.5. 
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3.5 DISCUSS ION 
This section describes the first biochemical characterisation 
of hypothalamic LH-RH from submammalian vertebrates. The isolation of 
LH-RH from hypothalami presents difficulties in view of the low total 
content and concentration of the peptide. This is particularly so in 
the avian hypothalamus in which the immunoreactive LH-RH content is 
considerably lower than in mammals. In the hypothalamus of the adult 
chicken and pigeon the content of irrununoreactive LH-RH as measured with 
antiserum 422, which requires the NH2 - and COOH-termini of the molecule 
for binding, was 2.8-4.3 ng (King and Millar, 1980). In the present 
study using hypothalami from immature chickens and dissection of a more 
discrete region (median eminence and pituitary stalk) to simplify 
purification, the hypothalamus contained only 0.135 ng, It was, there-
fore, necessary to process several hundred thousand hypothalami in 
order to isolate sufficient material for structural characterisation. 
A number of chromatographic systems were tested in studies preliminary 
to the final purification scheme. From these we selected a combination 
of anti-LH-RH affinity chromatography followed by only two HPLC systems 
which were sufficient to yield homo.geneously pure . peptide totalling 
17.4 µg. This represented a purification of two million-fold with an 
overall recovery from starting material of 51%. Contamination with 
non-LH-RH material as determined by amino acid analysis was less than 
1%. 
Amino acid analysis of the acid-hydrolysed peptide demon-
strated the presence of the same ratio of amino acids present in mammal-
ian LH-RH except for an absence of arginine and with an additional 
glutamic acid residue. The isoelectric point of chicken LH-RH (7.3) is 
consistent with a neutral amino acid replacing arginine at position 
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eight in the peptide. Thus glutamic acid is most likely represented 
as glutamine in the peptide. 
In view· of the structure of LH-RH (blocked NH2- and COOH-
termini and the presence of a proline residue at position nine), 
attempts to demonstrate glutamine by amino acid analysis of enzymic 
hydrolysates of the peptide and by microsequencing techniques were un-
successful and were not pursued further· owing to scarcity of material. 
Microsequencing studies were in collaboration with K, Bauer and J, 
Salnikow, Technische Universitat Berlin, West Germany, For solid-phase 
microsequencing, the COOH-terminal Gly10 -NH2 and NH2-terminal pGlu1 were 
first removed by incubation with post-proline-cleaving enzyme and 
pyroglutamate aminopeptidase, Various approaches to coupling the 
COOH-terminal Pro9 to aminopropyl glass were attempted hut all were 
unsuccessful, We therefore adopted the conventional liquid-phase 
sequencing technique after mild chymotrypsin cleavage of two µg of 
purified chicken LH-RH to generate presumed fragments LH-RH(l-5) and 
LH-RH(6-10). On Edman degradation residues six and seven, glycine and 
leucine, were identified in the first and second cycles respectively, 
The crucial position eight amino acid residue was undetectable in the 
third cycle. 
Indirect studies strongly support the conclusion that the 
only difference between chicken and mammalian LH-RH resides in the 
replacement of glutamine for arginine in the eight position with the 
retention of all other structural features includi~g pGlu1 and Gly10-NH2, 
The interaction of region-specific antisera with the peptide, and 
studies on the effects of chemical modification of specific amino acid , 
residues and cleavage of specific peptide bonds on immunoreactivity, 
all support this conclusion (see sections 2,4 and 2,5). It is also 
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pertinent that a common neutral amino acid substitution for arginine is 
glutamine (Dayhoff et aZ., 1972). Glutamine is also an appropriate 
neutral amino acid substitution for arginine if some semblance of the 
combined unit of hydrogen bond interactions between the side chains of 
His2 , Tyr 5 and Arg8 in mammalian LH-RH is to be retained (Shinitzky and 
Fridkin, 1976). These authors believe this combined ~unit is important 
for biological activity. Finally, the putative sequence of chicken 
LH-RH has been synthesised by conventional solid-phase methodology and 
shown to have identical physico-chemical properties to the natural 
chicken peptide (see sections 4.3 and 4.4). In contrast, other position 
eight-substituted LH-RH analogues had distinctly different properties. 
The nature of hypothalamic LH-RH in submammalian vertebrates 
has been studied by radioimmunoassay and chromatography (for reviews, 
see Ball, 1981; Jackson, 1981; King and Millar, 1981a). Several reports 
indicated a structural identity between mammalian hypothalamic LH-RH 
and chicken and frog hypothalamic LH-RHs (Deery, 1974; Jeffcoate et aZ., 
1974; Alpert et aZ., 1976) whilst others reported differences in the 
physico-chemical and biological properties of chicken and teleost fish 
hypothalamic LH-RHs (Jackson, 1971a, 1971b; Hattori et aZ., 1980; 
Jackson, 1981; Barnett et aZ., 1982). On the basis of chromatographic 
properties and using region-specific antisera we demonstrated that avian, 
reptilian, and piscine hypothalamic LH-RHs differed structurally from 
mammalian hypothalamic LH-RH, the difference being in the region 
-Gly6-Leu7-Arg8 (King and Millar, 1979a, 1980, 1981a). Amphibian 
hypothalamic LH-RH was, however, identical to the mammalian hypothalamic 
peptide (King and Millar, 1979a, 1980, 1981a), and this has been con-
firmed by recent studies on the amino acid composition of frog brain 
LH-RH (Rivier et aZ., 1981). It has now been shown in indirect studies 
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on partially purified material that chicken hypothalamic LH-RH differs 
structurally from the mammalian peptide by the substitution of glutamine 
for arginine in position eight (see sections 2.4 and 2.5), which accords 
with the findings presented in this section. 
Since hypothalamic LH-RHs from birds, reptiles and teleost 
fish behave identically on CM32 carboxymethyl cellulose cation exchange 
chromatography and reverse phase HPLC as well as in their interaction 
with region-specific antisera (King and Millar, 1979a, 1980, 1981a), 
it is possible that a substitution of glutamine for arginine of mammalian 
LH-RH is the characteristic structural feature of the peptide in all of 
these vertebrate classes. However, the HPLC system used in our early 
studies may not have been adequate to resolve certain neutral amino acid 
I 
substitutions in position eight from each other, and other position eight-
substituted analogues may be present in reptiles and fish. Thus, 
[GlnB]LH-RH (or another analogue with a conservative neutral amino acid 
substitution in position eight) is probably the ancestral molecule, and 
a mutation to [Arg8]LH-RH occurred in a line common to amphibians and 
mammals in accordance with a contemporary phylogenetic scheme (Licht 
et al., 1977; King and Millar, 1979a). 
Synthetic mammalian LH-RH has been found to exhibit good 
gonadotropin-releasing activity in amphibians but has 900~ or no such 
activity in birds, reptiles and fish (for reviews, see Ball, 1981; 
Jackson, 1981; King and Millar, 1981a). It is likely that this 
phenomenon reflects structural differences in pituitary gonadotrope 
receptors related to the structural difference of LH-RH in these 
vertebrate classes. 
4.0 SYNTHESIS AND BIOLOGICAL ACTIVITY OF CHICKEN HYPOTHALAMIC 
LUTEINIZING HORMONE-RELEASING HORMONE 
- 58 -
4.1 SUMMARY 
Chicken hypothalamic luteinizing hormone-releasing hormone 
(LH-RH), the isolation of which was described in section 3, was 
synthesised by solid-phase methodology, purified, and chemically 
characterised. The biological activity of the synthetic chicken 
peptide was compared with that of natural chicken LH-RH and synthetic 
mammalian LH-RH by assessment of luteinizing hormone (LH) release from 
dispersed chicken anterior pituitary cells and cultured ovine anterior 
pituitary cells, and binding to chicken and rat anterior pituitary 
cell membrane receptors was tested. Synthetic chicken LH-RH exhibited 
identical properties to the isolated natural chicken hypothalamic 
LH-RH in cation exchange and reverse phase high performance liquid 
chromatography (HPLC), and the isoelectric points of the synthetic and 
natural peptides were identical. Synthetic chicken LH-RH displayed 
identical .activity to natural chicken LH-RH in stimulating LH release 
from dispersed chicken anterior pituitary cells, and synthetic 
mammalian LH-RH was equipotent in this system. Both the natural 
and synthetic chicken peptides had similar low potency in stimulating 
LH release from cultured ovine anterior pituitary cells (approximately 
10% of the potency of synthetic manunalian LH-RH), and the EDso of bind-
ing .. to rat anterior pituitary cell membrane receptors was >10-s M (EDso 
for synthetic manunalian LH-RH was approximate.ly 10-7 M). 
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4.2 INTRODUCTORY STATEMENT 
Previous sections (2 and 3) provided strong evidence that 
-
chicken hypothalamic LH-RH differs from the mammalian hypothalamic 
peptide at amino acid residue eight, glutamine substituting for the 
arginyl residue of mammalian LH-RH. However, studies showing an 
identity of synthetic chicken LH-RH with the natural material in 
biological properties provide more conclusive evidence. This section 
I 
describes the solid-phase synthesis of chicken hypothalamic LH-RH, 
and studies on the biological properties of the peptide. The 
LH-releasing activities and receptor binding properties of natural 
chicken LH-RH, synthetic chicken LH-RH and synthetic mammalian 
LH-RH in the bird and in the mammal were compared, with a view to 




4,3 MATERIALS AND METHODS 
Peptide synthesis 
Chicken LH-RH was synthesised by R, P. Millar using the solid-
phase method of Merrifield (1963). The resin employed was chloromethyl-
ated polystyrene crosslinked with 1% divinyl benzene (Pierce). Amino 
acids of the L-configuration (gift from S. Jacobson) were coupled as 
their N-~-tert-butyloxycarbonyl (Boe) derivatives, and side chain 
functional groups were protected as follows: para-nitrophenyl for Gln; 
benzyl for Tyr and Ser; tosyl for His. Boc-Gly was attached to the resin 
by refluxing in ethanol and triethylamine for 24 hat 70°c. Four 
equivalents of each amino acid in CH2Cl2(or 10% dimethylformamide in 
CH2Cl2 for Tr~) were then successively coupled by mixing with four 
equivalents of dicyclohexylcarbodiimide in CH2Cl2 for 2 h, Completion 
of coupling was monitored at each step by the ninhydrin test or by the 
chloranil test when Pro was at the NH2 terminus. The Boe protection 
I 
residue was··removed at each step by treatment with 25% trifluoroacetic 
acid in CH2Cl2 for 30 min. Dithioethane (5%) was included after the 
addition of the Trp residue. The NH2-terminal pGlu was coupled using 
the pentachloride phenyl ester dissolved in dry dimethylformamide and 
mixed for 48 h. SimultaTieous cleavage of the peptide from the resin 
and amidation of the COOH-terminal Gly was achieved by stirring the 
peptide resin in dried liquified p~onia at ~
0 c in a sealed flask for 
48 h, Protective residues on side chains were removed by treatment 
with anhydrous liquid hydrogen fluoride containing 10% anisole for 30 
. 00 min at C. Hydrolysis of peptide coupled to resin was achieved using 
propionic acid/concentrated HCl (1 : 1), 
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Peptide purification and chemical characterisation 
HPLC was performed on a Model SP 3500B liquid chromatograph 
(Spectra-Physics) equipped with a Model 770 spectrophotometric detector 
(Spectra-Physics), Small aliquots (0.02 - 10.30 mg) of the crude 
peptide preparation were purified on a Spherisorb ODS reverse phase 
column (0.4 x 25 cm; 5 µm particle size; Phase Separations) using 
a mobile phase of 22% acetonitrile in 0,01 M ammonium acetate, pH 4,0. 
Flow rate was 1,5 ml/min, Absorbance was monitored at 280 nm, Peptide 
purity was assessed by amino acid analysis after hydrolysis in 100 µl 
constant boiling 6 N HCl containing 2% thioglycolic acid in sealed 
0 evacuated tubes at 110 C for 16 h, The hydrolysate was lyophilised, 
reconstituted in 0.15 M lithium citrate buffer , pH 2.2, and subjected 
to amino acid analysis (Beckman Instrwnents Model 121-MB), 
Release of LH from anterior pituitary cells 
The ability of natural chicken LH-RH, synthetic chicken LH-RH 
and synthetic mammalian LH-RH to stimulate the release of LH wa9 studied 
using dispersed chicken anterior pituitary cells and cultured ovine 
anterior pituitary cells, 
The dispersed chicken anterior pituitary cell bioassay was 
based on the method of Bonney and Cunningham (1977), Anterior pituit-
aries were dissected from chicken heads (South African Poultry Company, 
Cape Town, South Africa) collected on ice witbin 2 h of death, and 
placed in ice-cold, sterile Romanoff's avian Ringer's Albumin buffer 
(RRA) (147 mM NaCl, 4,15 mM KCl, 1,8 mM CaCl2, 0,49 mM _MgCl2,6H20, 
serum albumin (Pentex bovine albumin, fraction V; Miles Laboratories), 
pH 7,2). The anterior pituitaries were washed with RRA, diced, and 
incubated with stirring in HEPES buffer (137 mM NaCl, 5 mM KCl, 0.7 mM 
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Na2HP04 , 25 mM 4-2-hydroxyethyl piperazine ethanesulfonic acid, 0.36 
mM CaCl2, 10 mM glucose, and 1% bovine serum albumin, pH 7.2) contain-
ing 0.9% collagenase (155 U/mg, Worthington) and 1,8 mg% deoxyribonucl-
ease (Miles Laboratories) for l hat 37°c. After incubation the sus-
pension was passed up and down a pipette to aid dispersion, centrifuged 
at 50 g for 5 min, and the pellet was resuspended in RRA • .The cells 
were washed twice in RRA, counted, and distributed to polypropylene 
test-tubes (12 x 75 mm) at a concentration of approximately 2,5 x 105 
cells/tube. The tubes were pre-incubated in 1.5 ml RRA for 20 min at 
37°C with gentle shaking under a 90% water-saturated atmosphere of 4% 
CO 2 - 96% air. The cells were then centrifuged at 50 g for 5 min, 
the supernatant was poured off, and multiple dilutions of test substances 
were added in quadruplicate, to give a final incubation volume of 1,0 ml. 
The tubes were incubated for 2 h, centrifuged at 50 g for 5 min, and the 
supernatant was poured off into polypropylene vials, The supernatant 
was recentrifuged at 50 g for 5 min and an aliquot of the final super-
natant was assayed for LH immunoreactivity. 
Radioimmunoassay of chicken LH was as described by Follett 
et al. (1972), using the double-antibody technique. Chicken LH (gift 
from B.K. Follett) was used as standard, and for preparation of 125I-LH 
using the -chloramine T method (Greenwood et al., 1963) followed by 
purification by cellulose CF 11 chromatography (Whatman), Antiserum 
(gift from B.K. Follett) was raised against chicken LH.: Diluted 
aliquots of cell medium were assayed in duplicate, 
Culture of ovine anterior pituitary cells was according to 
the method of Vale et al. (1972), with modifications. Pituitaries 
dissected from sheep heads (Stanley Abattoir, Cape Town, South Africa) 
within 20 min of death were placed in ice-cold, sterile HEPES buffer 
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and the posterior pituitaries were removed. The anterior pituitaries 
were diced, rinsed with HEPES buffer, and incubated in HEPES buffer as 
described for chicken anterior pituitaries. At 10-min intervals coarse 
fragments were allowed to settle, and half of the supernatant was re-
moved and centrifuged at 50 g for 2-5 min. The supern~tant was returned 
to the incubation flask and the process was repeated until the bulk of 
the cells were dispersed. The cell pellets were pooled, washed with 
HEPES buffer, and suspended in Minimum Essential Medium (MEM, with 
Hank's salts) containing 10% donor calf serum and 0.1 rnM glutamine. 
Approximately 10 5 - 106 dispersed cells were distributed to tissue 
culture dishes (15 x 60 mm, Falcon Plastics) containing 3 ml medium, 
and incubated at 37°C under a 90% water-saturated atmosphere of 4% 
CO2 - 96% air. After 4-6 days in culture, the cells were washed six 
times with serum-free medium, and multiple dilutions of the test sub-
stances were added in triplicate. After 3 h of incubation, the medium 
was removed, centrifuged at 400 g for 5 min, and the supernatant was 
assayed for LH immunoreactivity. 
Radioimrnunoassay of ovine LH was as described by Millar and 
Aehnelt (1977), using the double-antibody technique. Ovine LH (gift 
from L.E. Reichert) was used as standard, and for preparation of 
125I-LH using the chlorarnine T method followed by purification by 
cellulose CF 11 chromatogr9 phy. Antiserum GDN 15 (gift from G.D. 
Niswender) was raised against ovine LH, Diluted aliquots of cell 
medium were assayed in duplicate. 
Potency of the peptides was estimated from parallel linear 
regressions (Rodbard and Lewald, 1970). 
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Anterior pituitary cell membrane receptor b i nding 
Binding of natural chicken LH-RH, synthetic chicken LH-RH 
and synthetic mammalian LH-RH to chicken and rat anterior pituitar~ 
cell membrane receptors was compared. 
A superactive, degradation-resistant analogue of mammalian 
LH-RH, [D-Trp6 ,des-Gly1D]LH-RH ethylamide (gift from W. Vale), was 
iodinated using chloramine T and purified on a CM32 carboxymethyl 
cellulose cation exchange column (1 x 30 cm; Whatman) eluted with a 
gradient of 0.06 M to 0.18 M ammonium acetate, pH 4,5, Specific activ-
ity of the 125I-labelled peptide, assessed by the self-displacement 
method using an antiserum to [D-Trp6]LH-RH (Barron et al., 1981), 
ranged from 800 - 1,000 µCi/µg. 
Fresh anterior pituitaries from chickens of mixed sex and 
age (South African Poultry Company, Cape Town, South Africa) and adult 
male rats (Long-Evans) were homogenised in a Dounce homogeniser in ice-
cold 10 mM Tris-HCl, pH 7,4, containing 1 mM dithiothreitol, 1.5 mM 
ethylenediaminetetra-acetic acid and 0.1% bovine serum albumin, and 
centrifuged at 1,000 g for 10 min at 4°C. The supernatant was centri-
fuged at 10,000 g for 20 min at 4°c to yield a crude membrane pellet 
which was washed twice and resuspended in th~ same buffer, Membrane 
fractions were assayed immediately after preparation, 
The binding assay procedure was as follows: approximately 
70,000 cpm 12 5I-labelled [D-Trp6,des-Gly1D]LH-RH ethylamide was incubat-
ed for 75 min at 4°C with the membrane preparation (2-4 chicken pituit-
ary equivalents/tube or 0.5 rat pituitary equivalents/tube) in the 
presence of increasing concentrations of the test peptides in glass 
test-tubes (12 x 75 mm) in a total volume of 0.5 ml of 10 mM Tris-HCl, 
pH 7.4, containing 0.1% bovine serum albumin, Incubation was terminated 
.., 
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by dilution with 3 ml ice-cold phosphate-buffered saline, pH 7.4, 
containing 1% bovine serum albumin ·(PBS-BSA), followed by immediate 
filtration under vacuum through glass fibre filters (GF/C; Whatman) 
presoaked in PBS-BSA. The filters were washed twice with 3 ml 
PBS-BSA, and the retained radioactivity was counted. All samples 




Reverse phase HPLC separated a single peak of synthetic chicken 
LH-RH from salts and contaminating peptides (Fig. 10), which co-eluted 
with natural chicken LH-RH. Amino acid analysis indicated the peptide 
was homogeneous, comprising the following ratios of amino acids 
Ser 0.74, Glu 2.04, Pro 1,00, Gly 2.01, Leu 1,03, Tyr 1,04, Trp 0.57 
and His 1.01. Synthetic chicken LH-RH and natural chicken LH-RH had 
identical retention times on reverse phase and cation exchange HPLC, 
and their isoelectric points were the same (see Table 7 in section 3.4), 
In radioimmunoassays employing four region-specific antisera, the immuno-
logical properties of the natural and synthetic materials were very 
similar in terms of slope of displacement curves and relative quantit-
ation with different antisera (see Fig. 6 in section 2,4). 
LB-releasing activity 
Natural and synthetic chicken LH-RH were equipotent in 
stimulating LH release from dispersed chicken anterior pituitary cells 
(Fig. llA), and synthetic mammalian LH-RH displayed a similar LH-
releasing activity (Fig. llB), 
Natural and synthetic chicken LH-RH stimulated LH release 
from cultured ovine anterior pituitary cells in a similar manner (Table 
8), Relative to synthetic mammalian LH-RH, the biological potency of 
synthetic chicken LH-RH in the ovine anterior pituitary cell bioassay 
was approximately 10% (Fig, 12), 
Receptor binding 
Binding of synthetic chicken LH-RH and synthetic mammalian 
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FIGURE 10 
Reverse phase HPLC purification of 0.5 mg of crude synthetic 
chicken LH-RH using 22% acetonitrile· in 0.01 M ammonium 
acetate , pH 4.0. Absorbance at 280 nm was recorded at a 
setting of 0.4 units full scale . One of several reverse phase 
HPLC runs is shown here; all column runs generated similar · 
UV absorbance peaks. The elution position of natural chicken 
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PEPTIDE DOSE (M) 
FIGURE 11 
Effect of natural and synthetic chicken LH-RH, and synthetic 
mammalian LH-RH, on LH release from d·i~persed chicken anterior 
pituitary cells . Peptide doses were determined hy amino acid 
analysis . Points represent mean± S.D. (n = 4). A, medium 
alone ( • ) , natural chicken LH-RH ( • •) and synthetic 
chicken LH-RH (0 0). B, medium alone(•), synthetic 
chicken LH-RH (0 0) and synthetic mammalian LH-RH 
(X K). Natural chicken LH-RH, synthetic chicken LH-RH 
and synthetic mammalian LH-RH were equipotent in stimulating 







Effect of natural and synthetic chicken LH-RH on LH release from 
cultured ovine anterior pituitary cells 
Peptide dosea 
Control (medium) 
Natural chicken LH-RH (10-8 ,M) 
Synthetic chicken LH-RH (10-8 M) 
Determined by amino acid analysis. 
Mean ± S . D • ( n = 3 ) • 
b C LH release ' 
(ng/ml)' 
42 ± 8 
81 ± 1 
75 ± 11 
Compared to the control value, stimulation of LH release by natural 
chicken LH-RH (P < 0.005) and synthetic chicken LH-RH (P < 0.01) 
was significant. Natural and synthetic chicken LH-RH were not 
significantly different from each other in their ability to 
stimulate LH release. 































Effect of medium alone ( •), synthetic chicken LH-RH ( o----0) 
and synthetic mammalian LH-RH (X X) on LH release from 
cultured ovine anterior pituitary cell s . Peptide doses were 
determ~ned by amino acid analysis . Points represent mean ± S.D. 
(n = 3). The potency of synthetic chicken LH-RH in stimulat i ng 
LH release was 14% relative to that of synthetic mammalian 
LH-RH (estimation of potency from parallel linear regressions). 
From three such experiments, the average potency of synthetic 
chicken LH-RH was 10%. 
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presumably due to the low concentration of LH-RH receptors in _the chicken 
anterior pituitary (approximately O.l fmol/pituitary). The experiment 
was repeated five times, but the data were not satisfactory and no con-
clusions could be made from them except to say that the concentration 
of receptors in the anterior pituitary was low. 
Synthetic chicken LH-RH bound to rat anterior pituitary cell 
membrane receptors with a lower affinity (EDso > l0- 5 M) ·than synthetic 

































PEPTIDE DOSE (M) 
Inhibition of 12 5I-labelled [D-Trp6 ,des-Gly10]LH-RH ethylamide 
binding to rat anterior pituitary cell membrane receptors by 
synthetic chicken LH-RH (o--~~--0) and synthetic mammalian 
LH-RH ( X K). The fraction of initial tracer bound 
(B/B
0
) is plotted on the ordinate. Peptide doses were deter-
mined by amino acid analysis. 
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4.5 DISCUSSION 
This section describes the synthesis of chicken hypothalamic 
LH-RH, the isolation of which was described in section 3. In addition 
to providing confirmation of the proposed primary structure of the 
natural compound, the synthesis has allowed more detailed biological 
characterisation of the peptide which was not possible on the minute 
quantitie~ of natural chicken LH-RH available. 
Synthetic and natural chicken LH-RH had identical chromato-
graphic properties and amino acid compositions, suggesting a correct 
assignment of structure of natural chicken LH-RH and demonstrating 
homogeneity of the synthetic compound. This was further emphasised 
by the similarity in their interaction with region-specific LH-RH 
antisera. Both peptides gave lowest quantitation and displacement 
curves nonparallel to synthetic mammalian LH-RH displacement curves 
with antiserum 744 which requires residues Arg8 to Gly10-NH2 for 
' effective binding; intermediate ~uantitation and nonparallel displace-
ment curves with the middle region-directed antisera 1076 and 743; and 
highest quantitation and parallel displacement curves ·with antiserum 
R-42 which requires NH2- and COOH-terrnini for binding, 
Previous studies have indicated that mammalian LH-RH has poor 
biological activity in birds (for reviews, see King and Millar, 1981a; 
section 1). We anticipated, therefore, that 'in birds chicken LH-RH 
would have greater biological activity than mammalian LH-RH. However, 
chicken LH-RH has similar properties to mammalian LH-RH in stimulating 
LH release from dispersed chicke.n anterior pituitary cells, 
Synthetic and natural chicken LH-RH had relatively poor 
potency in stimulating LH release from ovine anterior pituitary cells 
in culture (approximately 10% relative to synthetic mammalian LB-RH) 
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and in binding to rat anterior pituitary cell membrane receptors 
(En 50 > 10-s M). This finding is in accordance with data showing poor 
biological activity of position eight-substituted analogues of mammalian 
LH-RH in releasing LH from the mammalian pituitary (Yanaihara et al., 
1972; Sandow et al., 1978). 
Mammalian LH-RH has extremely low gonadotropin-releasing 
activity in fish (for reviews, see Ball, 1981; King and Millar, 1981a; 
section 1), Using a number of high re~olution chromatographic systems 
and radioimmunoassay with region-specific antisera we have shown that 
piscine LH-RH differs from mammalian LH-RH in the region Gly6-Leu7-Arg8 
(King and Millar, 1979a, 1980·, 1981a). Avian LH-RH might he a more 
potent stimulant of gonadotropin release in fish, and could he of 
economic importance in pisciculture. 
5.0 CONCLUDING DISCUSSION 
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The structure of chicken hypothalamic luteinizing hormone-
releasing hormone (LH-RH) was determined independently using two differ-
ent approaches. Firstly, an 'indirect' approach was taken since it was 
anticipated that sufficient material for conventional structural deter-
mination might not be obtained. A small quantity of partially purified 
material (immunoaffinity chromatography only) was studied using a com-
bination of chromatographic analysis, binding of region-specific anti-
sera, enzymic inactivation, and chemical modification of specific amino 
acid residues. This study established that the chicken peptide differs 
f~om mammalian hypothalamic LH-RH at residue eight, arginine being 
substituted by a neutral amino acid. On the basis of conformational 
criteria and evolutionary probability of amino acid interchange for 
arginine, we postulated that glutamine is the most likely substitute 
for arginine in position eight. The putative chicken LH-RH, [GlnB]LH-RH, 
was then synthesised, and found to have identical chromatographic and 
immunological properties to the natural chicken LH-RH, thus confirming 
the proposed primary structure of chicken hypothalamic LH-RH, 
I 
••••••••••••• 
Although we obtained substantial evidence that the structure 
of chicken LH-RH had been correctly assigned, direct determination of 
the amino acid composition and sequence of the pure peptide was 
desirabl~. 
In order to isolate pure chicken LH-RH, 249,000 hypothalami 
were collected, extracted wi~h acetic acid, and purified by immuno-
affinity chromatography followed by cation exchange and reverse phase 
high performance liquid chromatography to yield 17,4 µg of homogene-
ously pure peptide, Acid hydrolysis of the peptide showed an amino 
acid composition identical to that of mammalian decapeptide LH-RH, 
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except for the presence of an additional glutamic acid residue and· the 
absence of arginine, In order to ascertain whether the glutamic acid 
represented a glutamine residue as we had proposed in the 'indirect' 
study, amino acid analysis of enzymic hydrolysates and sequence analyses 
were performed, but were unsuccessful. The sequence -Gln8-Pro9- presents 
problems in that there is apparently resistance to cleavage and/or deriv-
ative formation during enzymic hydrolysis and in sequence analysis. The 
same difficulties in amino acid composition and sequence determination 
were encountered with synthetic [Gln8]LH-RH. In contrast, synthetic 
mammalian LH-RH was successfully analysed by these techniques. 
In spite of the inability to obtain definite proof of the 
structure of chicken LH-RH by sequence analysis , the demonstration of 
the amino acid composition (acid hydrolysis) , and the identity of pure 
natural chicken LH-RH with synthetic [Gln8]LH-RH in immunologic , chromato-
graphic and biological properties, together with the 'indirect ' studies, 




In order to provide more conclusive evidence for the identity of 
synthetic [GlnB]LH-RH with the natural chicken peptide, their biological 
properties were compared. Comparison with synthetic mammalian LH-RH 
was also made , with a view to obtaining further information on the evol-
ution of the peptide and its receptor. Natural and synthetic chicken 
LH-RH, and synthetic mammalian LH-RH, were equipotent in stimulating 
luteinizing hormone (LH) release from dispersed chicken anterior pit-
uitary cells, Both the natural and synthetic chicken peptides had sim-
ilar low potency in stimulating LH release from cultured ovine anterior 
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pituitary cell s (approximately 10% of the potency of synthetic mammalian 
LH-RH), and the EDso of binding to rat anterior pituitary cell membrane 
receptors was >10-s M, compared to an EDso of approximately 10-7 M for 
synthetic mammalian LH-RH • 
••••••••••••• 
Regarding the evolution of vertebrate hypothalamic LH-RH, we 
have previously demonstrated that avian, reptilian, and piscine hypo-
thalamic LH-RHs are structurally different from mammalian decapeptide 
LH-RH, but are indistinguishable from each other in chromatographic 
properties and in their interaction with several region-specific antisera 
(King and Millar, 1979a, 1980, 1981a). · It is possible, therefore, that a 
substitution of glutamine for arginine of mammalian LH-RH is the charac-
teristic structural feature of the peptide in these vertebrate classes. 
However, the HPLC system used in our early studies may not have been 
adequate to resolve certain neutral amino acid substitutions in position 
eight from each other, and other position eight-substituted analogues 
may be present in reptiles and fish. Amphibian hypothalamic LH-RH is 
identical to the mammalian decapeptide (King and Millar, 1979a, 1980, 
1981a; Rivier et al., 1981). Thus, [Gln8]LH-RH (or another analogue 
with a conservative neutral amino acid substitution in position eight) 
is probably the ancestral molecule, and a mutation to [Arg8]LH-RH 
occurred in a line common to amphibians and mammals in accordance with 
a contemporary phylogenetic scheme (Licht et al., 1977; King and Millar, 
1979a). 
• •••••••••••• 
Comments on the evolution of the pituitary gonadotrope receptor 
for LH-RH are largely speculative since there are not yet sufficient data 
to allow any definite proposals. A number of studies on the gonadotropin-
releasing activity of chicken LH-RH in different vertebrates have been 
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initiated by us, and the results of these studies might allow a more 
complete understanding of the evolution of the receptor. 
Synthetic mammalian LH-RH stimulates release of both LH and 
follicle-stimulating hormone (FSH) in mammals and in amphibians. In 
birds, reptiles and fish, however, higher doses of synthetic mammalian 
LH-RH are required to stimulate release of LH (in birds and reptiles) 
or gonadotropin (in fish), and the FSH response (in birds and reptiles) 
is very low even with extremely high doses of synthetic mammalian 
LH-RH (for reviews, see Ball, 1981; King · and Millar, 1981a; section 1), 
Synthetic chicken LH-RH has 10% of the potency of synthetic mammalian 
LH-RH in stimulating LH release in the mammal (present study); in the 
bird, synthetic chicken and mammalian LH-RHs are equipotent in stimulat-
ing LH release (present study); in amphibians, recent results indicate 
that . synthetic chicken and mammalian LH-RHs are equipotent in stimulat-
ing release of both LH and FSH (unpublished; studies in collaboration 
with P. Licht, University of California, Berkeley, California). Data 
from studies initiated on the gonadotropin-releasing activity of syn-
thetic chicken LH-RH in reptiles and fish are not yet available, Crude 
preparations of hypothalamic LH-RH from amphibians and fish have LH-
releasing activity in mammals (for reviews, see Ball, 1981; King and 
Millar, 1981a; section 1), but the potency of the peptides can obvious-
ly not be estimated in these studies. 
Based on the above data, the following comments can be made on 
the receptor for LH-RH. The mammalian receptor binds mammalian LH-RH, 
hut binding of chicken (avian) LH-RH is low, The avian receptor binds 
both mammalian and avian LH-RH, as does the amphibian receptor. Since 
[Gln8]LH-RH (or another analog~e with a conservative neutral amino acid 
substitution in position eight) appears to he the natural peptide in 
I 
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reptiles and fish, it is probable that the receptor in these vertebrate 
classes binds avian LH-RH well, Mammalian LH-RH, however, has low 
activity in reptiles and in fish. These speculations are summarised 
in Table 9. 
• •••••••••••• 
An interesting 'Concept which has emerged from our studies on 
the phylogenetic and anatomical distribution of LH-RH in vertebrates 
is consonant with 'Haeckel's Law' that ontogenesis recapitulates 
phylogenesis. On the basis of immunologic and chromatographic propert-
ies, it would appear that the LH-RH molecules in the hypothalamus of 
the bird, reptile and fish (King and Millar, 1979a, 1980, 1981a), in 
the amphibian sympathetic ganglion (Eiden and Eskay , 1980) and in the 
mammalian pineal gland (King and Millar, 1981c) all differ from mammal-
ian hypothalamic LH-RH, a conservative neutral amino acid substituting 
.for the arginyl residue in position eight, LH-RH in the mammalian 
extrahypothalamic brain (where LH-RH has effects but binds poorly to 
receptors) and in amphibian extrqhypothalamic brain might also have this 
structural difference, [Gln8]LH-RH (or another analogue with a con-
servative neutral amino acid substitution in position eight) which 
occurs in the hypothalamus of extant birds, reptiles and fish, but not 
in the hypothalamus of amphibians and mammals, is probably the ancestral 
, 
molecule. Elaboration of this ancestral LH-RH has apparently been re-
tained in some nerve tissues of amphibians and mammals, while the hypo-
thalamic LH-RH in these vertebrate classes (i.e. [Arg8]LH-RH) is more 
recently evolved, 
A similar evolutionary pattern is emerging for the neuro-
hypophysial hormones (Acher, 1978): the more primitive neurohypophysial 
hormone, arginine vasotocin, is present in the pineal gland 0f adult 





Biological activity of avian and mammalian LH-RHs 
in different vertebrate classes 
Biological activity in different vertebrates 
Mammal Bird Reptile Amphibian Fish 
+ +++ (+++) +++ (+++} 
Mammalian LH-RH +++ +++ (++) +++ (+) 
Plus signs indicate relative biological activity of LH-RH in different 
vertebrates: +++, full activity; ++, intermediate activity; +, low 
' 
activity. Brackets indicate predicted values-data not yet available, 
/ 
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